|
G |
Bbox1 |
gamma-butyrobetaine hydroxylase 1 |
multiple interactions |
ISO |
[BBOX1 protein co-treated with Ketoglutaric Acids] results in increased metabolism of gamma-butyrobetaine |
CTD |
PMID:21439360 |
|
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions increases abundance |
ISO |
Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of gamma-butyrobetaine] |
CTD |
PMID:27469509 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
|
G |
A2m |
alpha-2-macroglobulin |
decreases expression |
ISO |
Aminocaproic Acid results in decreased expression of A2M protein |
CTD |
PMID:11304663 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Folh1 |
folate hydrolase 1 |
multiple interactions |
ISO |
[2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [isospaglumic acid binds to FOLH1 protein] |
CTD |
PMID:24508213 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
G |
Grpr |
gastrin releasing peptide receptor |
multiple interactions |
ISO |
[2-(3-(1,3-dicarboxypropyl)ureido)pentanedioic acid binds to Aminocaproic Acid binds to 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane binds to Valerates binds to bombesin (7-14) binds to Copper] inhibits the reaction [bombesin, Tyr(4)- binds to GRPR protein] |
CTD |
PMID:24508213 |
|
NCBI chr X:30,998,425...31,038,442
Ensembl chr X:30,998,416...31,038,442
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:17482686 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:17482686 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Plg |
plasminogen |
multiple interactions |
ISO |
Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein]; Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:17482686 |
|
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
|
|
G |
Serpinc1 |
serpin family C member 1 |
increases expression |
ISO |
Aminocaproic Acid results in increased expression of SERPINC1 protein |
CTD |
PMID:11304663 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
increases expression multiple interactions increases activity |
ISO EXP |
diminazene aceturate results in increased expression of ACE2 mRNA; diminazene aceturate results in increased expression of ACE2 protein PD 123319 inhibits the reaction [diminazene aceturate results in increased expression of ACE2 protein] diminazene aceturate results in increased activity of ACE2 protein [Lipopolysaccharides co-treated with diminazene aceturate] results in increased expression of ACE2 mRNA; [Lipopolysaccharides co-treated with diminazene aceturate] results in increased expression of ACE2 protein; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR1 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; ACE2 protein affects the reaction [diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form]] |
CTD |
PMID:25301841 PMID:26862037 PMID:27550926 PMID:28688122 PMID:31982938 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of ACTA2 protein |
CTD |
PMID:29977014 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Agt |
angiotensinogen |
increases expression multiple interactions |
ISO |
diminazene aceturate results in increased expression of AGT protein modified form 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]]; ACE2 protein affects the reaction [diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGT protein]; diminazene aceturate promotes the reaction [Lipopolysaccharides results in increased expression of AGT protein alternative form] diminazene aceturate results in increased expression of AGT protein alternative form |
CTD |
PMID:25301841 PMID:26862037 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
ISO |
ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR1 mRNA]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR1 mRNA] |
CTD |
PMID:26862037 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
App |
amyloid beta precursor protein |
affects expression |
ISO |
diminazene aceturate affects the expression of APP protein alternative form |
CTD |
PMID:31982938 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression multiple interactions |
ISO |
diminazene aceturate results in decreased expression of MCP1 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] |
CTD |
PMID:26862037 PMID:29977014 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of COL1A1 protein |
CTD |
PMID:29977014 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cybb |
cytochrome b-245 beta chain |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of CYBB protein |
CTD |
PMID:29977014 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
increases phosphorylation |
ISO |
diminazene aceturate results in increased phosphorylation of GRIN2B protein |
CTD |
PMID:31982938 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression |
EXP ISO |
diminazene aceturate results in decreased expression of IL1B mRNA diminazene aceturate results in decreased expression of IL1B protein |
CTD |
PMID:25883526 PMID:31982938 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
decreases expression multiple interactions |
ISO EXP |
diminazene aceturate results in decreased expression of IL6 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:25883526 PMID:26862037 PMID:29977014 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
diminazene aceturate results in increased phosphorylation of MAPK1 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:26862037 PMID:31982938 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
decreases phosphorylation |
EXP |
diminazene aceturate results in decreased phosphorylation of MAPK14 protein |
CTD |
PMID:25883526 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
diminazene aceturate results in increased phosphorylation of MAPK3 protein 7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:26862037 PMID:31982938 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mas1 |
MAS1 proto-oncogene, G protein-coupled receptor |
increases expression |
ISO |
diminazene aceturate results in increased expression of MAS1 protein |
CTD |
PMID:31982938 |
|
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of NCF1 protein |
CTD |
PMID:29977014 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
decreases transport |
ISO |
diminazene aceturate results in decreased transport of NCF2 protein |
CTD |
PMID:29977014 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
7-Ala-angiotensin (1-7) inhibits the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; ACE2 protein affects the reaction [diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein]]; diminazene aceturate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:26862037 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos1 |
nitric oxide synthase 1 |
decreases expression |
EXP |
diminazene aceturate results in decreased expression of NOS1 mRNA |
CTD |
PMID:25883526 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nox1 |
NADPH oxidase 1 |
decreases expression |
ISO |
diminazene aceturate results in decreased expression of NOX1 protein |
CTD |
PMID:29977014 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases activity decreases expression |
EXP |
diminazene aceturate results in decreased activity of RELA protein diminazene aceturate results in decreased expression of RELA mRNA; diminazene aceturate results in decreased expression of RELA protein |
CTD |
PMID:25883526 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Smad2 |
SMAD family member 2 |
decreases phosphorylation |
ISO |
diminazene aceturate results in decreased phosphorylation of SMAD2 protein |
CTD |
PMID:29977014 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
decreases phosphorylation |
ISO |
diminazene aceturate results in decreased phosphorylation of SMAD3 protein |
CTD |
PMID:29977014 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression decreases secretion |
EXP ISO |
diminazene aceturate results in decreased expression of TNF mRNA; diminazene aceturate results in decreased expression of TNF protein diminazene aceturate results in decreased secretion of TNF protein |
CTD |
PMID:25883526 PMID:29977014 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Aanat |
aralkylamine N-acetyltransferase |
multiple interactions |
EXP |
Ketorolac Tromethamine results in decreased localization of and results in decreased activity of AANAT protein |
CTD |
PMID:37348669 |
|
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
|
|
G |
Cat |
catalase |
multiple interactions increases activity |
EXP |
Melatonin inhibits the reaction [Ketorolac Tromethamine results in increased activity of CAT protein] |
CTD |
PMID:37348669 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Ketorolac Tromethamine results in increased expression of EREG mRNA |
CTD |
PMID:32816093 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases activity |
EXP |
Ketorolac Tromethamine results in decreased activity of GPX1 protein |
CTD |
PMID:37348669 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity |
EXP |
Ketorolac Tromethamine results in increased activity of GSR protein |
CTD |
PMID:37348669 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
Ketorolac Tromethamine results in increased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions increases activity |
EXP |
Melatonin inhibits the reaction [Ketorolac Tromethamine results in increased activity of MAOA protein] |
CTD |
PMID:37348669 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Mtnr1a |
melatonin receptor 1A |
increases localization |
EXP |
Ketorolac Tromethamine results in increased localization of MTNR1A protein |
CTD |
PMID:37348669 |
|
NCBI chr16:47,144,461...47,163,919
Ensembl chr16:47,144,461...47,163,919
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Ketorolac Tromethamine results in increased expression of PTGS2 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
increases expression |
ISO |
Ketorolac Tromethamine results in increased expression of SLPI mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases activity |
EXP |
Ketorolac Tromethamine results in decreased activity of SOD1 protein |
CTD |
PMID:37348669 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases activity |
EXP |
Ketorolac Tromethamine results in decreased activity of SOD2 protein |
CTD |
PMID:37348669 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCA1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Bezafibrate] results in increased expression of ABCC2 mRNA |
CTD |
PMID:21549692 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ABCD1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ABCD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
|
|
G |
Acaa1a |
acetyl-CoA acyltransferase 1A |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACAA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:119,079,401...119,088,626
Ensembl chr 8:119,079,775...119,088,624
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACAA1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:118,872,996...118,881,852
Ensembl chr 8:118,872,997...118,881,825
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
decreases phosphorylation increases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased phosphorylation of ACACA protein Sodium Glutamate results in increased expression of ACACA mRNA; Sodium Glutamate results in increased expression of ACACA protein 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of ACACA mRNA]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of ACACA mRNA; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACACA mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACACA protein] |
CTD |
PMID:19724016 PMID:22415589 PMID:26670228 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACACB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655
|
|
G |
Acadl |
acyl-CoA dehydrogenase, long chain |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACADL mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ACADM mRNA SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACADM mRNA] |
CTD |
PMID:19724016 |
|
NCBI chr 2:242,858,865...242,883,036
Ensembl chr 2:242,858,865...242,883,147
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADS mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACADS mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACADS mRNA |
CTD |
PMID:19001666 PMID:23783067 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACADVL mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:54,732,875...54,738,102
Ensembl chr10:54,732,469...54,738,075
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions increases expression |
EXP |
Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of ACHE protein] Sodium Glutamate results in increased expression of ACHE mRNA |
CTD |
PMID:20928830 PMID:26900785 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acly |
ATP citrate lyase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACLY mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACO1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acot1 |
acyl-CoA thioesterase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACOT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
|
|
G |
Acot12 |
acyl-CoA thioesterase 12 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ACOT12 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:22,986,867...23,027,538
Ensembl chr 2:22,986,626...23,027,536
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ACOT2 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ACOT2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ACOT4 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ACOT4 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
multiple interactions |
EXP ISO |
[Taurine co-treated with Sodium Glutamate] results in increased expression of ACOX1 mRNA [Sodium Glutamate co-treated with Bezafibrate] results in increased expression of ACOX1 mRNA |
CTD |
PMID:21549692 PMID:26092479 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Acr |
acrosin |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ACR mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 7:120,636,581...120,644,474
Ensembl chr 7:120,638,321...120,644,474
|
|
G |
Acsbg1 |
acyl-CoA synthetase bubblegum family member 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ACSBG1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391
|
|
G |
Acsf2 |
acyl-CoA synthetase family member 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ACSF2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:79,504,510...79,546,714
Ensembl chr10:79,504,511...79,546,673
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACSL3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acvr2b |
activin A receptor type 2B |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ACVR2B mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
|
|
G |
Adam5 |
ADAM metallopeptidase domain 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ADAM5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:67,223,095...67,298,733
Ensembl chr16:67,223,143...67,298,737
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ADAMTS7 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ADAMTSL3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adcy5 |
adenylate cyclase 5 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ADCY5 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ADGRE1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of ADIPOQ protein [Sodium Glutamate co-treated with Pioglitazone] results in increased expression of ADIPOQ protein; [Sodium Glutamate co-treated with Plant Extracts] results in decreased expression of ADIPOQ mRNA; Bezafibrate inhibits the reaction [Sodium Glutamate results in decreased expression of ADIPOQ protein]; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in decreased expression of ADIPOQ protein] |
CTD |
PMID:21549692 PMID:27918843 PMID:32103741 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adora1 |
adenosine A1 receptor |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ADORA1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ADRA1A mRNA |
CTD |
PMID:19001666 |
|
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Adra1d |
adrenoceptor alpha 1D |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ADRA1D mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
|
|
G |
Agrp |
agouti related neuropeptide |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of AGRP mRNA |
CTD |
PMID:19151514 |
|
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
ISO |
Sodium Glutamate results in increased expression of AHR mRNA |
CTD |
PMID:19001666 PMID:22078008 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm3 |
apoptosis inducing factor, mitochondria associated 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of AIFM3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr11:83,504,859...83,523,630
Ensembl chr11:83,504,861...83,521,248
|
|
G |
Akr1a1 |
aldo-keto reductase family 1 member A1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of AKR1A1 mRNA; Sodium Glutamate results in increased expression of AKR1A1 protein |
CTD |
PMID:25473020 |
|
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of AKR1C6 mRNA |
CTD |
PMID:25473020 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation increases expression multiple interactions |
ISO EXP |
Sodium Glutamate results in decreased phosphorylation of AKT1 protein Sodium Glutamate results in increased expression of AKT1 protein Tea inhibits the reaction [Sodium Glutamate results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:29679905 PMID:36732937 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ALDH1A1 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ALDH1A3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Aldh1l2 |
aldehyde dehydrogenase 1 family, member L2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALDH1L2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ALDH3A1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Alg6 |
ALG6, alpha-1,3-glucosyltransferase |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ALG6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:114,404,972...114,454,440
Ensembl chr 5:114,405,010...114,454,439
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions increases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ALOX15 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ALOX15 mRNA Sodium Glutamate results in increased expression of ALOX15 mRNA |
CTD |
PMID:20111022 PMID:23783067 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Ambra1 |
autophagy and beclin 1 regulator 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of AMBRA1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:77,700,936...77,890,221
Ensembl chr 3:77,700,936...77,890,221
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ANXA1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of AP1M2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 8:19,838,579...19,856,560
Ensembl chr 8:19,838,580...19,856,482
|
|
G |
Apbb1 |
amyloid beta precursor protein binding family B member 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of APBB1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 1:159,896,889...159,920,505
Ensembl chr 1:159,896,880...159,920,627
|
|
G |
Apmap |
adipocyte plasma membrane associated protein |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of APMAP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:139,409,021...139,437,296
Ensembl chr 3:139,409,022...139,437,341
|
|
G |
Apoc2 |
apolipoprotein C2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of APOC2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
|
|
G |
Apod |
apolipoprotein D |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of APOD mRNA [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of APOD mRNA |
CTD |
PMID:19001666 PMID:20111022 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
increases expression multiple interactions |
ISO EXP |
Sodium Glutamate results in increased expression of APOE mRNA; Sodium Glutamate results in increased expression of APOE protein 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of APOE mRNA] |
CTD |
PMID:31981724 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ARAP3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:29,806,214...29,834,217
Ensembl chr18:29,807,536...29,833,555
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ARC mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Arg2 |
arginase 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ARG2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgef1 |
Rho guanine nucleotide exchange factor 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ARHGEF1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 1:80,499,026...80,520,954
Ensembl chr 1:80,499,131...80,520,953
|
|
G |
Arsb |
arylsulfatase B |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ARSB mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ATP1A3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp2b3 |
ATPase plasma membrane Ca2+ transporting 3 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ATP2B3 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
|
|
G |
Atp7b |
ATPase copper transporting beta |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ATP7B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Axin1 |
axin 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of AXIN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of BAMBI mRNA |
CTD |
PMID:22078008 |
|
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of BAX mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of BAX mRNA Sodium Glutamate results in increased expression of BAX mRNA Lycopene inhibits the reaction [Sodium Glutamate results in increased expression of BAX mRNA] |
CTD |
PMID:23783067 PMID:26900785 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bccip |
BRCA2 and CDKN1A interacting protein |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of BCCIP mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BCCIP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:188,512,544...188,524,957
Ensembl chr 1:188,512,367...188,524,958
|
|
G |
Bche |
butyrylcholinesterase |
increases activity multiple interactions |
EXP |
Sodium Glutamate results in increased activity of BCHE protein Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of BCHE protein] |
CTD |
PMID:26900785 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases expression decreases expression |
EXP ISO |
[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA; [Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 mRNA]; Folic Acid affects the reaction [[Homocysteine co-treated with Sodium Glutamate] affects the expression of BCL2 protein]; Lycopene inhibits the reaction [Sodium Glutamate results in decreased expression of BCL2 mRNA] SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of BCL2 mRNA] |
CTD |
PMID:16782274 PMID:22169520 PMID:26900785 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of BCL2L11 mRNA Sodium Glutamate results in increased expression of BCL2L11 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bend3 |
BEN domain containing 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of BEND3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:46,980,246...47,017,059
Ensembl chr20:46,979,831...47,014,671
|
|
G |
Bin3 |
bridging integrator 3 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BIN3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr15:45,173,725...45,212,607
Ensembl chr15:45,173,732...45,212,604
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of BMI1 mRNA Sodium Glutamate results in increased expression of BMI1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Bnip5 |
BCL2 interacting protein 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of BNIP5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:6,957,736...6,975,062
Ensembl chr20:6,956,201...6,975,091
|
|
G |
Bop1 |
BOP1 ribosomal biogenesis factor |
increases expression |
ISO |
Sodium Glutamate results in increased expression of BOP1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:108,172,062...108,195,875
Ensembl chr 7:108,172,066...108,195,931
|
|
G |
Brsk2 |
BR serine/threonine kinase 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of BRSK2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:197,035,505...197,088,624
Ensembl chr 1:197,035,633...197,088,092
|
|
G |
Bzw2 |
basic leucine zipper and W2 domains 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of BZW2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:52,828,069...52,888,599
Ensembl chr 6:52,827,661...52,888,628
|
|
G |
C1qtnf1 |
C1q and TNF related 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of C1QTNF1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:103,660,319...103,681,662
Ensembl chr10:103,660,327...103,681,660
|
|
G |
Cabp2 |
calcium binding protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CABP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CABP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:201,374,649...201,380,469
Ensembl chr 1:201,375,276...201,380,469
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNA1A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA1I mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNA1I mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cacna2d4 |
calcium voltage-gated channel auxiliary subunit alpha2delta 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNA2D4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNA2D4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:152,408,588...152,521,478
Ensembl chr 4:152,408,657...152,521,268
|
|
G |
Cacnb2 |
calcium voltage-gated channel auxiliary subunit beta 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
|
|
G |
Cacng4 |
calcium voltage-gated channel auxiliary subunit gamma 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNG4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:92,683,778...92,745,842
Ensembl chr10:92,683,761...92,746,126
|
|
G |
Cacng8 |
calcium voltage-gated channel auxiliary subunit gamma 8 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CACNG8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CACNG8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:65,755,334...65,775,567
Ensembl chr 1:65,755,334...65,779,089
|
|
G |
Calhm2 |
calcium homeostasis modulator family member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALHM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CALHM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
|
|
G |
Calr |
calreticulin |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of CALR mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Calr3 |
calreticulin 3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CALR3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CALR3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
increases expression |
EXP |
Sodium Glutamate results in increased expression of CAMK2A mRNA |
CTD |
PMID:20928830 |
|
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CAMK2B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Camlg |
calcium modulating ligand |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of CAMLG mRNA |
CTD |
PMID:20928830 |
|
NCBI chr17:8,992,697...9,003,576
Ensembl chr17:8,992,696...9,003,552
|
|
G |
Cant1 |
calcium activated nucleotidase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CANT1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CANT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:103,637,079...103,650,240
Ensembl chr10:103,531,504...103,650,109
|
|
G |
Caps2 |
calcyphosine 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CAPS2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:47,580,636...47,641,598
Ensembl chr 7:47,581,137...47,639,229
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of CAR2 mRNA |
CTD |
PMID:31569818 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Car5b |
carbonic anhydrase 5B |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of CAR5B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:30,474,697...30,534,797
Ensembl chr X:30,474,784...30,533,837
|
|
G |
Casp6 |
caspase 6 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CASP6 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CASP9 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CASP9 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression increases expression multiple interactions increases activity decreases activity |
ISO EXP |
Sodium Glutamate results in decreased expression of CAT mRNA Sodium Glutamate results in increased expression of CAT mRNA; Sodium Glutamate results in increased expression of CAT protein [Plant Extracts co-treated with Sodium Glutamate] results in increased activity of CAT protein; Sodium Glutamate results in increased expression of and results in decreased activity of CAT protein; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CAT mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CAT protein]; Tea inhibits the reaction [Sodium Glutamate results in decreased activity of CAT protein] Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of CAT protein]; Lycopene inhibits the reaction [Sodium Glutamate results in increased expression of CAT mRNA] |
CTD |
PMID:19724016 PMID:25473020 PMID:26319613 PMID:26900785 PMID:29679905 PMID:30733785 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Catsper1 |
cation channel, sperm associated 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CATSPER1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:202,643,009...202,652,059
Ensembl chr 1:202,643,038...202,651,824
|
|
G |
Catsper2 |
cation channel, sperm associated 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CATSPER2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:108,368,654...108,389,380
Ensembl chr 3:108,368,668...108,388,050
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases activity |
ISO |
Sodium Glutamate results in increased activity of CBR1 protein |
CTD |
PMID:25473020 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Ccdc138 |
coiled-coil domain containing 138 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CCDC138 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:26,493,624...26,572,367
Ensembl chr20:26,495,235...26,572,376
|
|
G |
Ccdc30 |
coiled-coil domain containing 30 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CCDC30 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:132,926,767...133,019,635
Ensembl chr 5:132,926,615...133,019,659
|
|
G |
Ccdc39 |
coiled-coil domain 39 molecular ruler complex subunit |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CCDC39 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:116,665,651...116,703,354
Ensembl chr 2:116,665,261...116,703,350
|
|
G |
Ccdc60 |
coiled-coil domain containing 60 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CCDC60 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:40,314,687...40,480,338
Ensembl chr12:40,314,713...40,480,225
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression increases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of CCL2 protein; [Sodium Glutamate co-treated with Aspartame] inhibits the reaction [Fats, Unsaturated results in increased expression of CCL2 protein]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CCL2 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CCL2 protein] Sodium Glutamate results in decreased expression of CCL2 mRNA Sodium Glutamate results in increased expression of CCL2 mRNA; Sodium Glutamate results in increased expression of CCL2 protein |
CTD |
PMID:19724016 PMID:20111022 PMID:23783067 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl21 |
C-C motif chemokine ligand 21 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of CCL21A mRNA Sodium Glutamate results in increased expression of CCL21A mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
|
|
G |
Ccnd2 |
cyclin D2 |
affects expression multiple interactions |
EXP ISO |
Sodium Glutamate affects the expression of CCND2 mRNA [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CCND2 mRNA |
CTD |
PMID:19001666 PMID:28954212 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression increases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of CCND3 mRNA Sodium Glutamate results in increased expression of CCND3 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CCND3 mRNA |
CTD |
PMID:20111022 PMID:22078008 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccng1 |
cyclin G1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CCNG1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Cd80 |
Cd80 molecule |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CD80 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
|
|
G |
Cd81 |
Cd81 molecule |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CD81 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CD86 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdcp2 |
CUB domain containing protein 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CDCP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:121,877,581...121,894,203
Ensembl chr 5:121,877,581...121,894,203
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CDH1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CDK5 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] affects the expression of CDKN1A mRNA |
CTD |
PMID:19001666 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of CDKN1C mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
decreases expression increases expression |
EXP ISO |
Sodium Glutamate results in decreased expression of CDKN2A mRNA; Sodium Glutamate results in decreased expression of CDKN2A protein Sodium Glutamate results in increased expression of CDKN2A mRNA |
CTD |
PMID:22078008 PMID:28954212 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
increases expression multiple interactions |
EXP ISO |
Sodium Glutamate results in increased expression of CDKN2B mRNA [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CDKN2B mRNA |
CTD |
PMID:19001666 PMID:28954212 |
|
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of CDKN2D mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CDS1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cep76 |
centrosomal protein 76 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CEP76 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504
|
|
G |
Cfd |
complement factor D |
multiple interactions decreases activity decreases expression |
ISO |
[Caffeine co-treated with Ephedrine] affects the reaction [Sodium Glutamate results in decreased expression of CFD mRNA]; [Caffeine co-treated with Ephedrine] affects the reaction [Sodium Glutamate results in decreased expression of CFD protein]; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CFD mRNA Sodium Glutamate results in decreased activity of CFD protein Sodium Glutamate results in decreased expression of CFD mRNA; Sodium Glutamate results in decreased expression of CFD protein |
CTD |
PMID:2307116 PMID:2734615 PMID:2798420 PMID:3299706 PMID:7961801 PMID:19001666 More...
|
|
NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
multiple interactions |
EXP |
Sodium Glutamate inhibits the reaction [CGA protein results in increased secretion of 7-hydroxyprogesterone]; Sodium Glutamate inhibits the reaction [CGA protein results in increased secretion of Androstenedione] |
CTD |
PMID:14657608 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Cherp |
calcium homeostasis endoplasmic reticulum protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CHERP mRNA |
CTD |
PMID:23783067 |
|
NCBI chr16:17,367,455...17,380,507
Ensembl chr16:17,367,455...17,380,507
|
|
G |
Chmp5 |
charged multivesicular body protein 5 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CHMP5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:56,081,385...56,098,529
Ensembl chr 5:56,081,343...56,098,529
|
|
G |
Chrnb3 |
cholinergic receptor nicotinic beta 3 subunit |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CHRNB3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:64,713,438...64,751,360
Ensembl chr16:64,714,169...64,751,360
|
|
G |
Chst1 |
carbohydrate sulfotransferase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CHST1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:78,552,059...78,574,740
Ensembl chr 3:78,548,525...78,574,883
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
decreases expression increases phosphorylation multiple interactions |
EXP ISO |
Sodium Glutamate results in decreased expression of CHUK mRNA Sodium Glutamate results in increased phosphorylation of CHUK protein Atorvastatin inhibits the reaction [Sodium Glutamate results in increased phosphorylation of CHUK protein] |
CTD |
PMID:19800637 PMID:28954212 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Ciao2a |
cytosolic iron-sulfur assembly component 2A |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CIAO2A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:66,670,533...66,682,455
Ensembl chr 8:66,670,483...66,682,455
|
|
G |
Ciart |
circadian associated repressor of transcription |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIART mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:183,419,819...183,424,845
Ensembl chr 2:183,419,819...183,423,313
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIDEA mRNA |
CTD |
PMID:19001666 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIDEC mRNA Sodium Glutamate results in increased expression of CIDEC mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Ckb |
creatine kinase B |
increases activity multiple interactions |
EXP |
Sodium Glutamate results in increased activity of CKB protein Lycopene inhibits the reaction [Sodium Glutamate results in increased activity of CKB protein] |
CTD |
PMID:26900785 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Clspn |
claspin |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CLSPN mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034
|
|
G |
Clstn3 |
calsyntenin 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CLSTN3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
|
|
G |
Cmc1 |
C-x(9)-C motif containing 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CMC1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CMC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:117,798,036...117,900,458
Ensembl chr 8:117,798,945...117,900,462
|
|
G |
Cmklr1 |
chemerin chemokine-like receptor 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of CMKLR1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129
|
|
G |
Cnih4 |
cornichon family member 4 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CNIH4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:92,910,315...92,926,428
Ensembl chr13:92,910,315...92,927,853
|
|
G |
Cnnm3 |
cyclin and CBS domain divalent metal cation transport mediator 3 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of CNNM3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:38,755,374...38,770,740
Ensembl chr 9:38,755,390...38,770,740
|
|
G |
Coa7 |
cytochrome c oxidase assembly factor 7 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of COA7 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:123,069,356...123,080,942
Ensembl chr 5:123,069,371...123,080,199
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of COL1A1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of COL3A1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Comp |
cartilage oligomeric matrix protein |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of COMP mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COMP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:19,047,206...19,055,584
Ensembl chr16:19,047,207...19,055,845
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of COMT mRNA |
CTD |
PMID:22078008 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cops3 |
COP9 signalosome subunit 3 |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COPS3 mRNA Sodium Glutamate results in increased expression of COPS3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:44,618,115...44,652,807
Ensembl chr10:44,618,115...44,641,597
|
|
G |
Coq10b |
coenzyme Q10B |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of COQ10B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:56,553,751...56,573,671
Ensembl chr 9:56,553,758...56,573,663
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of COTL1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cox11 |
cytochrome c oxidase copper chaperone COX11 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of COX11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:75,458,735...75,465,322
Ensembl chr10:75,458,749...75,465,322
|
|
G |
Cox4i2 |
cytochrome c oxidase subunit 4i2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of COX4I2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:141,228,443...141,239,337
Ensembl chr 3:141,228,443...141,239,331
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of COX7A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of COX7A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
increases expression |
ISO |
Sodium Glutamate results in increased expression of COX7A2L mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 6:11,184,064...11,198,287
Ensembl chr 6:11,184,285...11,198,273
|
|
G |
Cpne2 |
copine 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CPNE2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:10,434,277...10,472,146
Ensembl chr19:10,434,277...10,471,820
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions decreases expression |
EXP ISO |
Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of CPT1A mRNA] [Sodium Glutamate co-treated with Bezafibrate] results in increased expression of CPT1A mRNA |
CTD |
PMID:21549692 PMID:26092479 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
multiple interactions increases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1B mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CPT1B mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CPT1B mRNA; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of CPT1B mRNA] |
CTD |
PMID:19001666 PMID:19724016 PMID:23783067 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CPT2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Cpz |
carboxypeptidase Z |
increases expression |
EXP |
Sodium Glutamate results in increased expression of CPZ mRNA |
CTD |
PMID:20928830 |
|
NCBI chr14:75,223,692...75,246,946
Ensembl chr14:75,223,605...75,246,945
|
|
G |
Crat |
carnitine O-acetyltransferase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CRAT mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
affects expression increases expression multiple interactions decreases phosphorylation |
EXP ISO |
Sodium Glutamate affects the expression of CREB1 mRNA Sodium Glutamate results in increased expression of CREB1 mRNA 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of CREB1 mRNA]; Dizocilpine Maleate inhibits the reaction [Sodium Glutamate results in increased expression of CREB1 mRNA] [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CREB1 mRNA Sodium Glutamate results in decreased phosphorylation of CREB1 protein |
CTD |
PMID:23783067 PMID:28954212 PMID:31981724 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of CREBBP mRNA |
CTD |
PMID:28954212 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
multiple interactions decreases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CRELD2 mRNA Sodium Glutamate results in decreased expression of CRELD2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:119,909,633...119,916,543
|
|
G |
Crh |
corticotropin releasing hormone |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of CRH mRNA |
CTD |
PMID:8071649 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crtam |
cytotoxic and regulatory T cell molecule |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CRTAM mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:41,340,117...41,377,381
Ensembl chr 8:41,340,837...41,377,343
|
|
G |
Crtap |
cartilage associated protein |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of CRTAP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:114,047,929...114,067,636
Ensembl chr 8:114,047,933...114,067,631
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of CRY1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Crybg1 |
crystallin beta-gamma domain containing 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CRYBG1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:47,425,030...47,496,918
Ensembl chr20:47,426,183...47,621,392
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CSF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csf2rb |
colony stimulating factor 2 receptor subunit beta |
multiple interactions |
ISO |
[EPO protein co-treated with Sodium Glutamate] affects the expression of CSF2RB mRNA |
CTD |
PMID:30837834 |
|
NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:109,886,425...109,904,157
|
|
G |
Ctrl |
chymotrypsin-like |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CTRB1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CX3CR1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CXCL9 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cyb5b |
cytochrome b5 type B |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYB5B mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:35,062,871...35,096,741
Ensembl chr19:35,062,813...35,098,249
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP1A2 mRNA |
CTD |
PMID:25663641 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp20a1 |
cytochrome P450, family 20, subfamily a, polypeptide 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of CYP20A1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:61,755,804...61,805,123
Ensembl chr 9:61,755,790...61,805,123
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Sodium Glutamate results in increased expression of and results in increased activity of CYP2A1 protein |
CTD |
PMID:7476908 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2a2 |
cytochrome P450, family 2, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
Sodium Glutamate results in decreased expression of and results in decreased activity of CYP2A2 protein |
CTD |
PMID:7476908 |
|
NCBI chr 1:82,263,833...82,289,487
Ensembl chr 1:82,263,833...82,289,487
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2B10 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP2B10 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2B10 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CYP2B10 mRNA Sodium Glutamate results in increased expression of CYP2B10 mRNA |
CTD |
PMID:19001666 PMID:20111022 PMID:25663641 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
multiple interactions decreases expression decreases activity increases expression |
EXP |
[Sodium Glutamate co-treated with GH1 protein] results in decreased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased ubiquitination of CYP2C11 protein; GH1 protein affects the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; GH1 protein affects the reaction [Sodium Glutamate results in decreased expression of CYP2C11 mRNA]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of CYP2C11 protein]; Sodium Glutamate results in increased expression of and affects the splicing of CYP2C11 mRNA alternative form; Sodium Glutamate results in increased expression of and results in decreased splicing of CYP2C11 mRNA; Sodium Glutamate results in increased expression of and results in increased activity of CYP2C11 protein Sodium Glutamate results in increased expression of CYP2C11 mRNA; Sodium Glutamate results in increased expression of CYP2C11 mRNA alternative form; Sodium Glutamate results in increased expression of CYP2C11 protein |
CTD |
PMID:7476908 PMID:7965769 PMID:8496838 PMID:11089541 PMID:25697375 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c12 |
cytochrome P450, family 2, subfamily c, polypeptide 12 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of CYP2C12 mRNA; Sodium Glutamate results in increased expression of CYP2C12 protein |
CTD |
PMID:8010984 |
|
NCBI chr 1:238,699,859...238,757,011
Ensembl chr 1:238,699,854...238,757,019
|
|
G |
Cyp2c24 |
cytochrome P450, family 2, subfamily c, polypeptide 24 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP2C55 mRNA Sodium Glutamate results in increased expression of CYP2C55 mRNA |
CTD |
PMID:19001666 PMID:20111022 |
|
NCBI chr 1:236,873,967...236,936,238
Ensembl chr 1:236,873,967...236,936,238
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2C29 mRNA Sodium Glutamate results in increased expression of CYP2C29 mRNA |
CTD |
PMID:20111022 PMID:25663641 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP2C66 mRNA Sodium Glutamate results in increased expression of CYP2C66 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:237,078,517...237,169,841
Ensembl chr 1:237,078,517...237,169,650
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2D22 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2D22 mRNA |
CTD |
PMID:25663641 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP2E1 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP2E1 mRNA |
CTD |
PMID:25663641 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of and results in decreased activity of CYP3A2 protein]; Sodium Glutamate results in decreased expression of and results in decreased activity of CYP3A2 protein |
CTD |
PMID:7476908 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions decreases expression |
ISO EXP |
[Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP3A13 mRNA; [Sodium Glutamate co-treated with Tea] affects the expression of CYP3A13 mRNA Sodium Glutamate results in decreased expression of CYP3A9 mRNA |
CTD |
PMID:20928830 PMID:25663641 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO EXP |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of CYP46A1 mRNA]; Dizocilpine Maleate inhibits the reaction [Sodium Glutamate results in increased expression of CYP46A1 mRNA]; Dizocilpine Maleate inhibits the reaction [Sodium Glutamate results in increased expression of CYP46A1 protein] Sodium Glutamate results in increased expression of CYP46A1 mRNA; Sodium Glutamate results in increased expression of CYP46A1 protein |
CTD |
PMID:31981724 |
|
NCBI chr 6:127,247,543...127,274,765
Ensembl chr 6:127,243,315...127,274,760
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP7A1 mRNA Sodium Glutamate results in increased expression of CYP7A1 mRNA |
CTD |
PMID:19001666 PMID:20111022 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Dbndd1 |
dysbindin domain containing 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DBNDD1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:51,539,154...51,548,441
Ensembl chr19:51,539,148...51,548,444
|
|
G |
Dctn1 |
dynactin subunit 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of DCTN1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 4:115,671,024...115,703,824
Ensembl chr 4:115,661,638...115,703,815
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DCXR mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddx19b |
DEAD-box helicase 19B |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DDX19B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:38,968,215...38,998,907
Ensembl chr19:38,968,215...38,997,259
|
|
G |
Defb1 |
defensin beta 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of DEFB1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604
|
|
G |
Depdc1b |
DEP domain containing 1B |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DEPDC1B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
|
|
G |
Dglucy |
D-glutamate cyclase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of DGLUCY mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 6:120,055,480...120,130,910
Ensembl chr 6:120,055,460...120,130,910
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DIABLO mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of DIABLO mRNA |
CTD |
PMID:23783067 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of DLK1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dlx5 |
distal-less homeobox 5 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of DLX5 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of DNAJA1 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DNAJA1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnajc27 |
DnaJ heat shock protein family (Hsp40) member C27 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of DNAJC27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of DNAJC27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:27,068,713...27,098,449
Ensembl chr 6:27,068,686...27,098,449
|
|
G |
Dnal1 |
dynein, axonemal, light chain 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DNAL1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:103,747,801...103,779,015
Ensembl chr 6:103,747,753...103,778,878
|
|
G |
Dolpp1 |
dolichyldiphosphatase 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of DOLPP1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:13,666,000...13,674,312
Ensembl chr 3:13,665,823...13,674,311
|
|
G |
Dpys |
dihydropyrimidinase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DPYS mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
|
|
G |
Dsp |
desmoplakin |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of DSP mRNA Sodium Glutamate results in increased expression of DSP mRNA |
CTD |
PMID:19001666 |
|
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
|
|
G |
Duox2 |
dual oxidase 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DUOX2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Dynlt3 |
dynein light chain Tctex-type 3 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DYNLT3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
|
|
G |
Dzip1 |
DAZ interacting zinc finger protein 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of DZIP1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr15:95,956,329...96,009,994
Ensembl chr15:95,956,398...96,010,066
|
|
G |
E2f1 |
E2F transcription factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of E2F1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of E2F1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f3 |
E2F transcription factor 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of E2F3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
Ecel1 |
endothelin converting enzyme-like 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of ECEL1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 9:87,819,516...87,829,154
Ensembl chr 9:87,816,718...87,826,675
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ECH1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Efna1 |
ephrin A1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of EFNA1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:174,681,676...174,689,061
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression multiple interactions |
EXP ISO |
Sodium Glutamate results in decreased expression of EGFR mRNA [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of EGFR mRNA |
CTD |
PMID:19001666 PMID:28954212 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehhadh |
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EHHADH mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of EHHADH mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of EHHADH mRNA |
CTD |
PMID:19001666 PMID:23783067 |
|
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
|
|
G |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EIF2AK4 mRNA Sodium Glutamate results in increased expression of EIF2AK4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:105,356,261...105,441,630
Ensembl chr 3:105,356,261...105,441,630
|
|
G |
Eif4ebp2 |
eukaryotic translation initiation factor 4E binding protein 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of EIF4EBP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
|
|
G |
Elane |
elastase, neutrophil expressed |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ELANE mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Elmo3 |
engulfment and cell motility 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ELMO3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:33,181,952...33,186,399
Ensembl chr19:33,182,036...33,186,410
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
multiple interactions |
ISO |
3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of ELOVL6 mRNA]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of ELOVL6 mRNA |
CTD |
PMID:26670228 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of EMILIN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Emp1 |
epithelial membrane protein 1 |
multiple interactions decreases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EMP1 mRNA Sodium Glutamate results in decreased expression of EMP1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of EPHX2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of EPHX2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epo |
erythropoietin |
increases expression multiple interactions affects expression |
EXP ISO |
Sodium Glutamate results in increased expression of EPO mRNA [EPO protein co-treated with Sodium Glutamate] affects the expression of CSF2RB mRNA; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPO protein; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR mRNA; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR protein; EPO protein inhibits the reaction [Sodium Glutamate results in increased expression of EPO mRNA] Sodium Glutamate affects the expression of EPO protein |
CTD |
PMID:30837834 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
multiple interactions increases expression |
ISO EXP |
[EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR mRNA; [EPO protein co-treated with Sodium Glutamate] results in increased expression of EPOR protein Sodium Glutamate results in increased expression of EPOR protein |
CTD |
PMID:30837834 |
|
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of ERBB3 mRNA Sodium Glutamate results in increased expression of ERBB3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erlin1 |
ER lipid raft associated 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ERLIN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:242,921,147...242,956,472
Ensembl chr 1:242,921,152...242,956,394
|
|
G |
Esrrb |
estrogen-related receptor beta |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ESRRB mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:106,007,701...106,163,136
Ensembl chr 6:106,008,095...106,160,791
|
|
G |
Exosc8 |
exosome component 8 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EXOSC8 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
Ezh1 |
enhancer of zeste 1 polycomb repressive complex 2 subunit |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of EZH1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:86,126,023...86,162,001
Ensembl chr10:86,126,015...86,161,921
|
|
G |
Faap24 |
FA core complex associated protein 24 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of FAAP24 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:88,051,523...88,057,997
Ensembl chr 1:88,051,911...88,057,989
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FABP5 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fads1 |
fatty acid desaturase 1 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FADS1 mRNA Sodium Glutamate results in increased expression of FADS1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:206,827,724...206,842,734
Ensembl chr 1:206,827,765...206,842,734
|
|
G |
Fads2 |
fatty acid desaturase 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FADS2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of FAIM mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FAIM2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam78b |
family with sequence similarity 78, member B |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of FAM78B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500
|
|
G |
Fan1 |
FANCD2 and FANCI associated nuclease 1 |
affects methylation |
EXP |
Sodium Glutamate affects the methylation of FAN1 gene |
CTD |
PMID:29381301 |
|
NCBI chr 1:117,915,323...117,945,044
Ensembl chr 1:117,917,099...117,944,977
|
|
G |
Faslg |
Fas ligand |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of FASL mRNA SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of FASL mRNA] |
CTD |
PMID:16782274 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions increases expression |
ISO EXP |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FASN mRNA; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of FASN mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of FASN protein] Sodium Glutamate results in increased expression of FASN mRNA; Sodium Glutamate results in increased expression of FASN protein |
CTD |
PMID:19001666 PMID:19724016 PMID:26092479 PMID:32103741 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat3 |
FAT atypical cadherin 3 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of FAT3 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135
|
|
G |
Fbln1 |
fibulin 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of FBLN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbn2 |
fibrillin 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FBN2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
|
|
G |
Fbxo15 |
F-box protein 15 |
affects methylation |
EXP |
Sodium Glutamate affects the methylation of FBXO15 gene |
CTD |
PMID:29381301 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo41 |
F-box protein 41 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FBXO41 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:118,007,517...118,039,547
Ensembl chr 4:118,010,978...118,039,406
|
|
G |
Fdps |
farnesyl diphosphate synthase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FDPS mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF21 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FGF8 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FGFR2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of FLT1 protein |
CTD |
PMID:28755050 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of FMO2 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of FMO2 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of FMO2 mRNA |
CTD |
PMID:19001666 PMID:20111022 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Fmod |
fibromodulin |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FMOD mRNA |
CTD |
PMID:19001666 |
|
NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133
|
|
G |
Folr2 |
folate receptor beta |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of FOLR2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:156,200,044...156,218,380
Ensembl chr 1:156,200,060...156,205,724
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of FOS mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxb2 |
forkhead box B2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FOXB2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:214,232,731...214,234,226
Ensembl chr 1:214,232,731...214,234,226
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of FOXO3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp4 |
forkhead box P4 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of FOXP4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:13,058,506...13,115,406
Ensembl chr 9:13,058,476...13,114,879
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases secretion |
ISO |
Sodium Glutamate results in decreased secretion of FSHB protein |
CTD |
PMID:30733785 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Ftcd |
formimidoyltransferase cyclodeaminase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of FTCD mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:12,055,203...12,068,717
Ensembl chr20:12,055,208...12,068,735
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of FXYD6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
G0s2 |
G0/G1switch 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of G0S2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of G6PDX mRNA |
CTD |
PMID:19001666 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
increases expression decreases expression |
EXP |
Sodium Glutamate results in increased expression of GAD1 protein Sodium Glutamate results in decreased expression of GAD1 mRNA |
CTD |
PMID:19733649 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
affects expression increases expression decreases expression |
EXP |
Sodium Glutamate affects the expression of GAD2 protein Sodium Glutamate results in increased expression of GAD2 mRNA Sodium Glutamate results in decreased expression of GAD2 protein |
CTD |
PMID:19733649 |
|
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
multiple interactions increases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GADD45B mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GADD45B mRNA Sodium Glutamate results in increased expression of GADD45B mRNA |
CTD |
PMID:19001666 PMID:20111022 PMID:23783067 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gale |
UDP-galactose-4-epimerase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GALE mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
|
|
G |
Galk1 |
galactokinase 1 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GALK1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GALK1 mRNA Sodium Glutamate results in increased expression of GALK1 mRNA |
CTD |
PMID:19001666 PMID:20111022 |
|
NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of GALNT10 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:41,821,216...41,967,618
Ensembl chr10:41,820,158...41,967,013
|
|
G |
Galp |
galanin-like peptide |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GALP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:67,684,023...67,703,121
Ensembl chr 1:67,684,025...67,702,269
|
|
G |
Gas2l1 |
growth arrest-specific 2 like 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of GAS2L1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:79,955,350...79,961,830
Ensembl chr14:79,950,555...79,961,438
|
|
G |
Gbe1 |
1,4-alpha-glucan branching enzyme 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GBE1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
|
|
G |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of GDPD5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GFAP mRNA |
CTD |
PMID:20928830 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfm2 |
GTP dependent ribosome recycling factor mitochondrial 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of GFM2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of GFM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:28,449,452...28,488,200
Ensembl chr 2:28,449,517...28,488,197
|
|
G |
Gfod2 |
Gfo/Idh/MocA-like oxidoreductase domain containing 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GFOD2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:33,599,689...33,647,060
Ensembl chr19:33,604,187...33,647,004
|
|
G |
Gh1 |
growth hormone 1 |
affects expression decreases expression decreases secretion multiple interactions |
EXP |
Sodium Glutamate affects the expression of GH1 protein Sodium Glutamate results in decreased expression of GH1 mRNA; Sodium Glutamate results in decreased expression of GH1 protein Sodium Glutamate results in decreased secretion of GH1 protein [Octreotide co-treated with Sodium Glutamate] results in decreased expression of and results in decreased secretion of GH1 protein; [Sodium Glutamate co-treated with GH1 protein] results in decreased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased splicing of CYP2C11 mRNA; [Sodium Glutamate co-treated with GH1 protein] results in increased ubiquitination of CYP2C11 protein; GH1 protein affects the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; GH1 protein affects the reaction [Sodium Glutamate results in decreased expression of CYP2C11 mRNA]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased activity of CYP2C11 protein]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of and results in decreased activity of CYP3A2 protein]; GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of IGF1 mRNA]; GH1 protein inhibits the reaction [Sodium Glutamate results in increased expression of IGF1R mRNA]; GHRH protein affects the reaction [Sodium Glutamate results in decreased expression of GH1 mRNA]; JI-38 inhibits the reaction [Sodium Glutamate results in decreased secretion of GH1 protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in decreased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of CYP2C11 protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR protein]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 protein]; Sodium Glutamate inhibits the reaction [GHRL protein results in increased secretion of GH1 protein]; Sodium Glutamate results in decreased expression of and results in decreased secretion of GH1 protein |
CTD |
PMID:7476908 PMID:7711889 PMID:8368293 PMID:8496838 PMID:9053782 PMID:10718930 PMID:12193538 PMID:25697375 More...
|
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Ghdc |
GH3 domain containing |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of GHDC mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:85,693,612...85,697,833
Ensembl chr10:85,693,616...85,697,865
|
|
G |
Ghr |
growth hormone receptor |
increases expression multiple interactions |
EXP |
Sodium Glutamate results in increased expression of GHR mRNA; Sodium Glutamate results in increased expression of GHR protein Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of GHR protein] |
CTD |
PMID:25697375 |
|
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
|
|
G |
Ghrh |
growth hormone releasing hormone |
multiple interactions decreases expression |
EXP |
[Sodium Glutamate co-treated with Octreotide] results in decreased expression of GHRH mRNA; GHRH protein affects the reaction [Sodium Glutamate results in decreased expression of GH1 mRNA] Sodium Glutamate results in decreased expression of GHRH mRNA |
CTD |
PMID:2004597 PMID:8368293 PMID:9053782 |
|
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
|
|
G |
Ghrhr |
growth hormone releasing hormone receptor |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GHRHR mRNA |
CTD |
PMID:10718930 |
|
NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
multiple interactions |
EXP |
Sodium Glutamate inhibits the reaction [GHRL protein results in increased secretion of GH1 protein] |
CTD |
PMID:12193538 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GHSR mRNA |
CTD |
PMID:10718930 |
|
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
|
|
G |
Gigyf1 |
GRB10 interacting GYF protein 1 |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GIGYF1 mRNA Sodium Glutamate results in increased expression of GIGYF1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:19,166,070...19,181,570
Ensembl chr12:19,166,088...19,175,023
|
|
G |
Gip |
gastric inhibitory polypeptide |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of GIP protein; Sodium Glutamate inhibits the reaction [Aspartame promotes the reaction [Fats, Unsaturated results in increased expression of GIP protein]] |
CTD |
PMID:23783067 |
|
NCBI chr10:80,968,360...80,976,506
Ensembl chr10:80,968,352...80,976,503
|
|
G |
Gk |
glycerol kinase |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of GK mRNA Sodium Glutamate results in increased expression of GK mRNA |
CTD |
PMID:19001666 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Glrx |
glutaredoxin |
decreases expression multiple interactions increases expression |
ISO |
Sodium Glutamate results in decreased expression of GLRX mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GLRX mRNA Sodium Glutamate results in increased expression of GLRX mRNA |
CTD |
PMID:20111022 PMID:22078008 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
multiple interactions |
EXP |
Sodium Glutamate results in decreased expression of and results in decreased activity of GLUD1 protein |
CTD |
PMID:11807584 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gmeb2 |
glucocorticoid modulatory element binding protein 2 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GMEB2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 3:168,362,650...168,400,788
Ensembl chr 3:168,362,650...168,400,788
|
|
G |
Gmfb |
glia maturation factor, beta |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GMFB mRNA |
CTD |
PMID:22078008 |
|
NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331
|
|
G |
Gnpat |
glyceronephosphate O-acyltransferase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GNPAT mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:52,822,326...52,848,872
Ensembl chr19:52,822,319...52,852,361
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of GOT1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GPAT3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpc2 |
glypican 2 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GPC2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr12:17,277,875...17,284,297
Ensembl chr12:17,277,875...17,284,208
|
|
G |
Gpr85 |
G protein-coupled receptor 85 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GPR85 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566
|
|
G |
Gprc5c |
G protein-coupled receptor, class C, group 5, member C |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GPRC5C mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:99,886,900...99,908,928
Ensembl chr10:99,887,077...99,908,926
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression decreases expression increases activity multiple interactions |
ISO |
Sodium Glutamate results in increased expression of GPT protein Sodium Glutamate results in decreased expression of GPT protein Sodium Glutamate results in increased activity of GPT protein 2-ethoxy-3-(4-(2-(4-trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid promotes the reaction [Sodium Glutamate results in increased activity of GPT protein]; 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of GPT protein]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of GPT protein; Bezafibrate promotes the reaction [Sodium Glutamate results in increased expression of GPT protein]; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in increased expression of GPT protein]; Rosiglitazone promotes the reaction [Sodium Glutamate results in increased activity of GPT protein] |
CTD |
PMID:18048028 PMID:19724016 PMID:21205225 PMID:21549692 PMID:26670228 PMID:32103741 More...
|
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression increases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of GPX1 mRNA Sodium Glutamate results in increased expression of GPX1 mRNA; Sodium Glutamate results in increased expression of GPX1 protein SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of GPX1 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of GPX1 protein] |
CTD |
PMID:19724016 PMID:30733785 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases expression affects expression |
ISO |
Sodium Glutamate results in decreased expression of GPX2 protein Sodium Glutamate affects the expression of GPX2 mRNA |
CTD |
PMID:25473020 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
affects expression multiple interactions |
ISO EXP |
Sodium Glutamate affects the expression of GRIA2 protein SB 203580 affects the reaction [Sodium Glutamate affects the expression of GRIA2] |
CTD |
PMID:15139026 PMID:16782274 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grifin |
galectin-related inter-fiber protein |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GRIFIN mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:14,080,170...14,082,892
Ensembl chr12:14,080,910...14,082,877
|
|
G |
Grik3 |
glutamate ionotropic receptor kainate type subunit 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GRIK3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
|
|
G |
Grik5 |
glutamate ionotropic receptor kainate type subunit 5 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GRIK5 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GRIN1 |
CTD |
PMID:15139026 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
EXP |
Sodium Glutamate results in increased expression of GRIN2C mRNA |
CTD |
PMID:11872244 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Grin2d |
glutamate ionotropic receptor NMDA type subunit 2D |
decreases expression increases expression |
EXP |
Sodium Glutamate results in decreased expression of GRIN2D mRNA Sodium Glutamate results in increased expression of GRIN2D mRNA |
CTD |
PMID:11872244 PMID:20928830 |
|
NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity multiple interactions |
ISO |
Sodium Glutamate results in decreased activity of GSR protein Sodium Glutamate results in increased expression of and results in decreased activity of GSR protein; Tea inhibits the reaction [Sodium Glutamate results in decreased activity of GSR protein] |
CTD |
PMID:25473020 PMID:29679905 PMID:30733785 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GSTM2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstm4 |
glutathione S-transferase mu 4 |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GSTM4 mRNA Sodium Glutamate results in increased expression of GSTM4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
|
|
G |
Gstm5 |
glutathione S-transferase, mu 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of GSTM3 mRNA |
CTD |
PMID:19001666 PMID:25473020 |
|
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of GSTP1 protein |
CTD |
PMID:29441869 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gtf2b |
general transcription factor IIB |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of GTF2B mRNA Sodium Glutamate results in increased expression of GTF2B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
|
|
G |
Guca1a |
guanylate cyclase activator 1A |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of GUCA1A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:13,588,988...13,598,566
Ensembl chr 9:13,588,525...13,598,565
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of H1F4 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of H1F4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of HACD2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of HADHA mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hadhb |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HADHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of HADHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:26,153,578...26,184,869
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of HAO2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
multiple interactions decreases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of HCN1 mRNA Sodium Glutamate results in decreased expression of HCN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac5 |
histone deacetylase 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HDAC5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
|
|
G |
Hddc2 |
HD domain containing 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of HDDC2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:26,294,030...26,313,914
Ensembl chr 1:26,294,030...26,313,935
|
|
G |
Heatr6 |
HEAT repeat containing 6 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of HEATR6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:68,635,048...68,665,445
Ensembl chr10:68,635,065...68,664,105
|
|
G |
Heatr9 |
HEAT repeat containing 9 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of HEATR9 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:68,309,128...68,320,650
Ensembl chr10:68,308,579...68,319,376
|
|
G |
Hebp1 |
heme binding protein 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of HEBP1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
|
|
G |
Hes2 |
hes family bHLH transcription factor 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of HES2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:162,667,190...162,668,235
Ensembl chr 5:162,667,190...162,668,235
|
|
G |
Heyl |
hes-related family bHLH transcription factor with YRPW motif-like |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of HEYL mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HGF mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hmox1 |
heme oxygenase 1 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of HMOX1 mRNA; Sodium Glutamate results in decreased expression of HMOX1 protein Tea inhibits the reaction [Sodium Glutamate results in decreased expression of HMOX1 mRNA]; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of HMOX1 protein] |
CTD |
PMID:29679905 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hoxc10 |
homeo box C10 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of HOXC10 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:134,103,741...134,108,966
Ensembl chr 7:134,103,643...134,108,966
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of HRAS mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of HSD11B1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of HSD3B2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of HSD3B7 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442
|
|
G |
Hsf4 |
heat shock transcription factor 4 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of HSF4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:33,147,755...33,153,479
Ensembl chr19:33,147,755...33,153,479
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of HSPA5 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of HSPB1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspg2 |
heparan sulfate proteoglycan 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of HSPG2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
|
|
G |
Htr6 |
5-hydroxytryptamine receptor 6 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of HTR6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of IDH2 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of IDH2 mRNA |
CTD |
PMID:20111022 PMID:23783067 |
|
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of IDI1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Iffo2 |
intermediate filament family orphan 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of IFFO2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:151,830,900...151,876,948
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression |
ISO |
Plant Extracts inhibits the reaction [Sodium Glutamate results in decreased expression of IFNG protein] |
CTD |
PMID:27918843 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions decreases secretion decreases expression |
ISO EXP |
[Sodium Glutamate co-treated with Azoxymethane] affects the expression of IGF1 mRNA GH1 protein inhibits the reaction [Sodium Glutamate results in decreased expression of IGF1 mRNA]; JI-38 inhibits the reaction [Sodium Glutamate results in decreased secretion of IGF1 protein] Sodium Glutamate results in decreased expression of IGF1 mRNA; Sodium Glutamate results in decreased expression of IGF1 protein |
CTD |
PMID:7533119 PMID:7711889 PMID:8368293 PMID:10718930 PMID:22223845 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions increases expression |
ISO EXP |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of IGF1R mRNA; Sodium Glutamate affects the reaction [Azoxymethane affects the expression of IGF1R mRNA] GH1 protein inhibits the reaction [Sodium Glutamate results in increased expression of IGF1R mRNA] |
CTD |
PMID:7711889 PMID:19001666 PMID:22223845 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Azoxymethane] affects the expression of IGF2 mRNA |
CTD |
PMID:22223845 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of IGFBP3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
increases phosphorylation multiple interactions |
ISO |
Sodium Glutamate results in increased phosphorylation of IKBKB protein Atorvastatin inhibits the reaction [Sodium Glutamate results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:19800637 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of IL10 protein |
CTD |
PMID:27918843 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18rap |
interleukin 18 receptor accessory protein |
increases expression |
ISO |
Sodium Glutamate results in increased expression of IL18RAP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
|
|
G |
Il1b |
interleukin 1 beta |
increases response to substance |
EXP |
Sodium Glutamate results in increased susceptibility to IL1B protein |
CTD |
PMID:12077204 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rl2 |
interleukin 1 receptor-like 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of IL1RL2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 9:42,591,658...42,639,351
Ensembl chr 9:42,591,934...42,636,667
|
|
G |
Il2 |
interleukin 2 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of IL2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il21 |
interleukin 21 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of IL21 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
|
|
G |
Il6 |
interleukin 6 |
increases expression affects expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of IL6 mRNA; Sodium Glutamate results in increased expression of IL6 protein Sodium Glutamate affects the expression of IL6 mRNA; Sodium Glutamate affects the expression of IL6 protein [Sodium Glutamate co-treated with Pioglitazone] results in decreased expression of IL6 protein; [Sodium Glutamate co-treated with Plant Extracts] results in decreased expression of IL6 protein; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of IL6 protein]; Glycine affects the reaction [Sodium Glutamate affects the expression of IL6 mRNA]; Glycine affects the reaction [Sodium Glutamate affects the expression of IL6 protein]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA]; Plant Extracts inhibits the reaction [Sodium Glutamate results in increased expression of IL6 mRNA] |
CTD |
PMID:18930730 PMID:19800637 PMID:21205225 PMID:25834641 PMID:27918843 PMID:28708105 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Immt |
inner membrane mitochondrial protein |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IMMT mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of IMMT mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Ing4 |
inhibitor of growth family, member 4 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ING4 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ING4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:157,841,882...157,850,519
Ensembl chr 4:157,841,951...157,850,265
|
|
G |
Ino80e |
INO80 complex subunit E |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of INO80E mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:181,461,406...181,472,059
Ensembl chr 1:181,461,408...181,472,469
|
|
G |
Inpp5j |
inositol polyphosphate-5-phosphatase J |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of INPP5J mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:78,374,161...78,385,305
Ensembl chr14:78,374,161...78,385,326
|
|
G |
Ins1 |
insulin 1 |
multiple interactions increases expression increases secretion decreases expression |
ISO EXP |
3,3',4',5,7-pentamethylquercetin inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of INS1 protein; [Sodium Glutamate co-treated with Tea] affects the expression of INS1 protein; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; Azoxymethane inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; fructooligosaccharide inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein]; Rosiglitazone inhibits the reaction [Sodium Glutamate results in increased expression of INS1 protein] Sodium Glutamate results in increased secretion of INS1 protein Sodium Glutamate results in decreased expression of INS1 protein Carbenoxolone inhibits the reaction [Sodium Glutamate results in increased secretion of INS1 protein] |
CTD |
PMID:11319642 PMID:18930730 PMID:19001666 PMID:19800637 PMID:20111022 PMID:21205225 PMID:21549692 PMID:21999347 PMID:22223845 PMID:22415589 PMID:25473020 PMID:25663641 PMID:31077719 PMID:32103741 More...
|
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] results in increased expression of INS2 protein; [Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of INS2 protein |
CTD |
PMID:23783067 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Iqch |
IQ motif containing H |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of IQCH mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:63,889,816...64,083,248
Ensembl chr 8:63,892,370...64,083,223
|
|
G |
Ireb2 |
iron responsive element binding protein 2 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of IREB2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 8:55,228,080...55,311,613
Ensembl chr 8:55,228,085...55,311,611
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of IRF2BP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
|
|
G |
Irs2 |
insulin receptor substrate 2 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of IRS2 mRNA 2-ethoxy-3-(4-(2-(4-trifluoromethanesulfonyloxyphenyl)ethoxy)phenyl)propionic acid inhibits the reaction [Sodium Glutamate results in decreased expression of IRS2 mRNA] |
CTD |
PMID:18048028 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Itfg2 |
integrin alpha FG-GAP repeat containing 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ITFG2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:161,684,249...161,698,315
Ensembl chr 4:161,684,249...161,698,422
|
|
G |
Itga2b |
integrin subunit alpha 2b |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ITGA2B mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of ITGA2B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
|
|
G |
Itga7 |
integrin subunit alpha 7 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ITGA7 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
|
|
G |
Itgav |
integrin subunit alpha V |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ITGAV mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Itgb3 |
integrin subunit beta 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ITGB3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Itm2a |
integral membrane protein 2A |
multiple interactions decreases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of ITM2A mRNA Sodium Glutamate results in decreased expression of ITM2A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:72,486,383...72,492,344
Ensembl chr X:72,486,381...72,492,363
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of ITPR3 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ITPR3 mRNA |
CTD |
PMID:19001666 PMID:20111022 |
|
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
|
|
G |
Kcnh1 |
potassium voltage-gated channel subfamily H member 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of KCNH1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
|
|
G |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of KCNJ12 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:45,696,621...45,745,528
Ensembl chr10:45,696,849...45,745,492
|
|
G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KCNJ16 mRNA Sodium Glutamate results in increased expression of KCNJ16 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
|
|
G |
Kcnk1 |
potassium two pore domain channel subfamily K member 1 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KCNK1 mRNA Sodium Glutamate results in increased expression of KCNK1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
|
|
G |
Kcnn2 |
potassium calcium-activated channel subfamily N member 2 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of KCNN2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
|
|
G |
Kdelr3 |
KDEL endoplasmic reticulum protein retention receptor 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of KDELR3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
|
|
G |
Kdr |
kinase insert domain receptor |
increases expression multiple interactions |
EXP |
Sodium Glutamate results in increased expression of KDR protein [Semaxinib co-treated with Sodium Glutamate] results in increased expression of KDR protein |
CTD |
PMID:28755050 PMID:36732937 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of KIRREL3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:32,865,779...33,407,555
Ensembl chr 8:32,862,776...33,405,676
|
|
G |
Klhl3 |
kelch-like family member 3 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of KLHL3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr17:6,523,089...6,645,971
Ensembl chr17:6,521,912...6,642,154
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of KRAS mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Krt19 |
keratin 19 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of KRT19 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Ldhd |
lactate dehydrogenase D |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LDHD mRNA Sodium Glutamate results in increased expression of LDHD mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:39,583,529...39,588,397
Ensembl chr19:39,573,621...39,595,575
|
|
G |
Ldlr |
low density lipoprotein receptor |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LDLR mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lep |
leptin |
multiple interactions affects expression increases expression |
ISO EXP |
[Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein]; [Sodium Glutamate co-treated with Aurothioglucose] results in increased expression of LEP mRNA; [Sodium Glutamate co-treated with Aurothioglucose] results in increased expression of LEP protein; [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of LEP protein; [Sodium Glutamate co-treated with Tea] affects the expression of LEP protein; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LEP mRNA; [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of LEP protein; Bezafibrate inhibits the reaction [Sodium Glutamate results in increased expression of LEP protein]; Glycine affects the reaction [Sodium Glutamate affects the expression of LEP protein]; Sodium Glutamate promotes the reaction [Fats, Unsaturated results in increased expression of LEP protein] Sodium Glutamate results in increased expression of LEP mRNA; Sodium Glutamate results in increased expression of LEP protein |
CTD |
PMID:7489415 PMID:7657836 PMID:9794456 PMID:14657608 PMID:15809509 PMID:18930730 PMID:19001666 PMID:19093718 PMID:21205225 PMID:21549692 PMID:23783067 PMID:24502529 PMID:25473020 PMID:25663641 More...
|
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals4 |
galectin 4 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of LGALS4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:84,124,766...84,132,481
Ensembl chr 1:84,124,764...84,132,481
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases secretion |
ISO |
Sodium Glutamate results in decreased secretion of LHB protein |
CTD |
PMID:30733785 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Limk1 |
LIM domain kinase 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of LIMK1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
|
|
G |
Lin54 |
lin-54 DREAM MuvB core complex component |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of LIN54 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:9,129,775...9,188,244
Ensembl chr14:9,130,336...9,187,790
|
|
G |
Lipe |
lipase E, hormone sensitive type |
decreases activity decreases expression |
EXP |
Sodium Glutamate results in decreased activity of LIPE protein Sodium Glutamate results in decreased expression of LIPE mRNA |
CTD |
PMID:11319642 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Lipg |
lipase G, endothelial type |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LIPG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of LOXL1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Lpin1 |
lipin 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of LPIN1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lrp1 |
LDL receptor related protein 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
|
|
G |
Lrp2 |
LDL receptor related protein 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:54,189,305...54,346,769
Ensembl chr 3:54,189,308...54,346,708
|
|
G |
Lrp4 |
LDL receptor related protein 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of LRP4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:77,429,600...77,483,593
Ensembl chr 3:77,429,798...77,483,593
|
|
G |
Lrpap1 |
LDL receptor related protein associated protein 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of LRPAP1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414
|
|
G |
Lrrc26 |
leucine rich repeat containing 26 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of LRRC26 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:8,102,361...8,103,687
Ensembl chr 3:8,102,361...8,103,687
|
|
G |
Lrrc46 |
leucine rich repeat containing 46 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of LRRC46 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:82,021,314...82,033,575
Ensembl chr10:82,021,330...82,033,724
|
|
G |
Lrrc73 |
leucine rich repeat containing 73 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of LRRC73 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:14,726,157...14,730,144
Ensembl chr 9:14,726,158...14,729,158
|
|
G |
Luc7l |
LUC7-like |
increases expression |
ISO |
Sodium Glutamate results in increased expression of LUC7L mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:15,273,340...15,307,131
Ensembl chr10:15,273,348...15,303,112
|
|
G |
Ly6m |
lymphocyte antigen 6 family member M |
increases expression |
ISO |
Sodium Glutamate results in increased expression of LY6M mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:106,863,167...106,867,047
Ensembl chr 7:106,865,291...106,867,047
|
|
G |
Magt1 |
magnesium transporter 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MAGT1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:71,038,489...71,079,704
Ensembl chr X:71,038,489...71,079,699
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of MAOA mRNA Sodium Glutamate results in increased expression of MAOA mRNA |
CTD |
PMID:20111022 |
|
NCBI chr X:6,032,172...6,098,308
Ensembl chr X:6,030,795...6,099,593
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP2K1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP2K2 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP2K3 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP2K4 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP3K1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Map3k15 |
mitogen-activated protein kinase kinase kinase 15 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of MAP3K15 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:34,713,150...34,859,054
Ensembl chr X:34,713,175...34,858,807
|
|
G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP3K3 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr10:91,020,174...91,088,852
Ensembl chr10:91,020,174...91,088,848
|
|
G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAP4K1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
|
|
G |
Mapk12 |
mitogen-activated protein kinase 12 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAPK12 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
|
|
G |
Mapk13 |
mitogen activated protein kinase 13 |
affects expression |
EXP |
Sodium Glutamate affects the expression of MAPK13 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr20:6,835,277...6,845,500
Ensembl chr20:6,835,320...6,844,222
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAPK8 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MAPK8IP1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 3:78,355,051...78,372,946
Ensembl chr 3:78,355,048...78,372,884
|
|
G |
Mbd4 |
methyl-CpG binding domain 4 DNA glycosylase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MBD4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:148,893,049...148,904,833
Ensembl chr 4:148,894,280...148,904,982
|
|
G |
Mc4r |
melanocortin 4 receptor |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of MC4R mRNA |
CTD |
PMID:20111022 |
|
NCBI chr18:60,419,832...60,421,719
Ensembl chr18:60,419,832...60,421,719
|
|
G |
Mcfd2 |
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MCFD2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
|
|
G |
Mcu |
mitochondrial calcium uniporter |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MCU mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MCU mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:27,417,529...27,580,110
Ensembl chr20:27,417,526...27,580,110
|
|
G |
Mdh1 |
malate dehydrogenase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of MDH1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
|
|
G |
Mdk |
midkine |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of MDK mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Med12l |
mediator complex subunit 12L |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of MED12L mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:143,253,048...143,576,507
Ensembl chr 2:143,252,139...143,573,741
|
|
G |
Med23 |
mediator complex subunit 23 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MED23 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:20,490,315...20,558,461
Ensembl chr 1:20,490,315...20,537,463
|
|
G |
Med31 |
mediator complex subunit 31 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MED31 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:56,836,944...56,840,326
Ensembl chr10:56,836,944...56,840,326
|
|
G |
Mef2d |
myocyte enhancer factor 2D |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MEF2D mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:173,606,054...173,635,620
Ensembl chr 2:173,606,490...173,634,457
|
|
G |
Megf10 |
multiple EGF-like domains 10 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MEGF10 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:50,605,231...50,755,441
Ensembl chr18:50,605,656...50,754,456
|
|
G |
Mgll |
monoglyceride lipase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of MGLL mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MICAL3 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 4:154,152,776...154,353,274
Ensembl chr 4:154,153,834...154,302,590
|
|
G |
Micos10 |
mitochondrial contact site and cristae organizing system subunit 10 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MINOS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MINOS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:151,341,124...151,367,403
Ensembl chr 5:151,339,176...151,367,485
|
|
G |
Micos13 |
mitochondrial contact site and cristae organizing system subunit 13 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MICOS13 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:1,439,841...1,441,782
Ensembl chr 9:1,439,058...1,442,076
|
|
G |
Micu1 |
mitochondrial calcium uptake 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MICU1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MICU1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:27,668,681...27,816,322
Ensembl chr20:27,668,747...27,814,964
|
|
G |
Mir142 |
microRNA 142 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MIR142 mRNA |
CTD |
PMID:25697375 |
|
NCBI chr10:72,557,864...72,557,950
Ensembl chr10:72,557,857...72,557,967
|
|
G |
Mir223 |
microRNA 223 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of MIR223 mRNA |
CTD |
PMID:25697375 |
|
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mlxipl |
MLX interacting protein-like |
decreases expression multiple interactions |
EXP |
Sodium Glutamate results in decreased expression of MLXIPL mRNA Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of MLXIPL mRNA] |
CTD |
PMID:26092479 |
|
NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
|
|
G |
Mmd |
monocyte to macrophage differentiation-associated |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of MMD mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:75,073,278...75,101,528
Ensembl chr10:75,073,365...75,101,528
|
|
G |
Mmp28 |
matrix metallopeptidase 28 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MMP28 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:68,241,138...68,264,866
Ensembl chr10:68,241,138...68,264,866
|
|
G |
Mplkip |
M-phase specific PLK1 interacting protein |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MPLKIP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr17:47,373,624...47,376,199
Ensembl chr17:47,373,845...47,376,204
|
|
G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL20 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPL20 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:166,408,962...166,413,492
Ensembl chr 5:166,408,962...166,413,492
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPL3 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:105,670,184...105,693,544
Ensembl chr 8:105,670,184...105,693,544
|
|
G |
Mrpl35 |
mitochondrial ribosomal protein L35 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MRPL35 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:103,865,812...103,876,687
Ensembl chr 4:103,865,812...103,880,887
|
|
G |
Mrps12 |
mitochondrial ribosomal protein S12 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:84,025,896...84,028,896
Ensembl chr 1:84,025,899...84,028,780
|
|
G |
Mrps14 |
mitochondrial ribosomal protein S14 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MRPS14 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
|
|
G |
Mrps24 |
mitochondrial ribosomal protein S24 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS24 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871
|
|
G |
Mrps27 |
mitochondrial ribosomal protein S27 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS27 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS27 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:30,740,007...30,808,577
Ensembl chr 2:30,740,033...30,808,577
|
|
G |
Mrps7 |
mitochondrial ribosomal protein S7 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:100,843,691...100,846,838
Ensembl chr10:100,843,356...100,847,129
|
|
G |
Ms4a2 |
membrane spanning 4-domains A2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MS4A2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:208,440,179...208,448,716
Ensembl chr 1:208,440,361...208,448,310
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ND6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mtfp1 |
mitochondrial fission process 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MTFP1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MTFP1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:78,968,434...78,972,274
Ensembl chr14:78,968,442...78,972,274
|
|
G |
Mtmr12 |
myotubularin related protein 12 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of MTMR12 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:61,223,714...61,293,270
Ensembl chr 2:61,223,851...61,293,197
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
decreases expression multiple interactions |
EXP |
Sodium Glutamate results in decreased expression of MTTP mRNA Taurine inhibits the reaction [Sodium Glutamate results in decreased expression of MTTP mRNA] |
CTD |
PMID:26092479 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Mvk |
mevalonate kinase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MVK mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
|
|
G |
Mycbpap |
Mycbp associated protein |
increases expression |
ISO |
Sodium Glutamate results in increased expression of MYCBPAP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:79,450,319...79,470,977
Ensembl chr10:79,450,324...79,470,828
|
|
G |
Myo7a |
myosin VIIA |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of MYO7A mRNA Sodium Glutamate results in increased expression of MYO7A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
|
|
G |
Ncaph |
non-SMC condensin I complex, subunit H |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NCAPH mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NCOR1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ndufa10 |
NADH:ubiquinone oxidoreductase subunit A10 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NDUFA10 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 9:93,007,034...93,041,825
Ensembl chr 9:93,007,042...93,042,560
|
|
G |
Ndufa12 |
NADH:ubiquinone oxidoreductase subunit A12 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFA12 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:28,771,330...28,798,316
Ensembl chr 7:28,771,330...28,798,315
|
|
G |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of NDUFA13 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
multiple interactions decreases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFA5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFA5 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] affects the expression of NDUFA5 mRNA Sodium Glutamate results in decreased expression of NDUFA5 mRNA |
CTD |
PMID:20111022 PMID:23783067 |
|
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598
|
|
G |
Ndufb10 |
NADH:ubiquinone oxidoreductase subunit B10 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB10 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFB10 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:13,749,273...13,751,434
Ensembl chr10:13,749,275...13,751,442
|
|
G |
Ndufb2 |
NADH:ubiquinone oxidoreductase subunit B2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
|
|
G |
Ndufb4 |
NADH:ubiquinone oxidoreductase subunit B4 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NDUFB4 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:63,063,723...63,070,426
Ensembl chr11:63,063,795...63,070,425
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFB6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFB6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:55,400,543...55,410,110
Ensembl chr 5:55,400,543...55,410,181
|
|
G |
Ndufb8 |
NADH:ubiquinone oxidoreductase subunit B8 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of NDUFB8 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
|
|
G |
Ndufc1 |
NADH:ubiquinone oxidoreductase subunit C1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NDUFC1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
multiple interactions decreases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFS1 mRNA Sodium Glutamate results in decreased expression of NDUFS1 mRNA |
CTD |
PMID:20111022 PMID:23783067 |
|
NCBI chr 9:64,546,430...64,579,751
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Ndufs4 |
NADH:ubiquinone oxidoreductase subunit S4 |
multiple interactions increases expression decreases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] affects the expression of NDUFS4 mRNA Sodium Glutamate results in increased expression of NDUFS4 mRNA Sodium Glutamate results in decreased expression of NDUFS4 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:45,951,313...46,061,846
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase subunit S6 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFS6 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFS6 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NDUFS7 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NDUFV1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of NDUFV1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Neb |
nebulin |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NEB mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574
|
|
G |
Nek11 |
NIMA-related kinase 11 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NEK11 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:105,767,230...106,026,676
Ensembl chr 8:105,770,548...106,026,676
|
|
G |
Neu3 |
neuraminidase 3 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of NEU3 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 1:154,137,732...154,148,879
Ensembl chr 1:154,050,855...154,148,813
|
|
G |
Nf1 |
neurofibromin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:64,306,027...64,539,112
Ensembl chr10:64,306,301...64,536,658
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression multiple interactions increases expression |
ISO |
Sodium Glutamate results in decreased expression of NFE2L2 mRNA; Sodium Glutamate results in decreased expression of NFE2L2 protein Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 mRNA]; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NFE2L2 protein] Sodium Glutamate results in increased expression of NFE2L2 mRNA |
CTD |
PMID:25473020 PMID:29679905 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NFIL3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases expression |
ISO |
Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of NFKB1 mRNA] |
CTD |
PMID:28708105 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
EXP |
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of NFKBIB mRNA |
CTD |
PMID:21999347 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nfya |
nuclear transcription factor Y subunit alpha |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NFYA mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:12,587,437...12,613,911
Ensembl chr 9:12,586,259...12,613,898
|
|
G |
Ngfr |
nerve growth factor receptor |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of TNFRSF10B mRNA |
CTD |
PMID:20111022 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nherf4 |
NHERF family PDZ scaffold protein 4 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of NHERF4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:44,584,390...44,588,838
Ensembl chr 8:44,584,390...44,588,860
|
|
G |
Nipal1 |
NIPA-like domain containing 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NIPAL1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr14:35,537,641...35,561,656
Ensembl chr14:35,540,324...35,561,659
|
|
G |
Nol3 |
nucleolar protein 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NOL3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP |
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of NOS2 mRNA; [Fenofibrate co-treated with Sodium Glutamate] results in increased expression of NOS2 protein Sodium Glutamate results in increased expression of NOS2 protein |
CTD |
PMID:21999347 PMID:36732937 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOTCH1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NOX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nptx1 |
neuronal pentraxin 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NPTX1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:104,811,107...104,820,358
Ensembl chr10:104,811,403...104,820,367
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
ISO EXP |
Sodium Glutamate results in decreased expression of NPY mRNA |
CTD |
PMID:9794456 PMID:19151514 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions decreases expression increases expression |
ISO |
[Plant Extracts co-treated with Sodium Glutamate] results in increased activity of NQO1 protein; Sodium Glutamate results in increased expression of and results in increased activity of NQO1 protein; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of NQO1 mRNA] Sodium Glutamate results in increased expression of NQO1 mRNA |
CTD |
PMID:25473020 PMID:26319613 PMID:29679905 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of NR0B2 mRNA [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of NR0B2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression multiple interactions |
ISO EXP |
Sodium Glutamate results in increased expression of NR1H3 mRNA 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Sodium Glutamate results in increased expression of NR1H3 mRNA] |
CTD |
PMID:31981724 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions increases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of NR1I3 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of NR1I3 mRNA Sodium Glutamate results in increased expression of NR1I3 mRNA |
CTD |
PMID:20111022 PMID:23783067 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NR4A2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NSMCE1 mRNA Sodium Glutamate results in increased expression of NSMCE1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:180,030,355...180,058,541
Ensembl chr 1:180,030,160...180,058,417
|
|
G |
Nudt17 |
nudix hydrolase 17 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NUDT17 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:184,241,468...184,243,960
Ensembl chr 2:184,241,468...184,243,960
|
|
G |
Nudt2 |
nudix hydrolase 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of NUDT2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:56,628,265...56,643,104
Ensembl chr 5:56,628,265...56,643,104
|
|
G |
Nudt7 |
nudix hydrolase 7 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of NUDT7 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:42,125,679...42,151,198
Ensembl chr19:42,125,711...42,151,081
|
|
G |
Onecut1 |
one cut homeobox 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ONECUT1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:75,599,432...75,633,598
Ensembl chr 8:75,599,740...75,627,277
|
|
G |
Opn1mw |
opsin 1, medium wave sensitive |
increases expression |
EXP |
Sodium Glutamate results in increased expression of OPN1MW mRNA |
CTD |
PMID:20928830 |
|
NCBI chr X:151,905,056...151,925,419
Ensembl chr X:151,905,096...151,925,388
|
|
G |
Or4c11 |
olfactory receptor family 4 subfamily C member 11 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of OR4C11 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of OR4C11 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:74,598,809...74,599,732
Ensembl chr 3:74,579,912...74,603,428
|
|
G |
Osbpl6 |
oxysterol binding protein-like 6 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of OSBPL6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:61,343,776...61,541,170
Ensembl chr 3:61,343,809...61,537,102
|
|
G |
Pak1 |
p21 (RAC1) activated kinase 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of PAK1 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
|
|
G |
Paqr4 |
progestin and adipoQ receptor family member 4 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PAQR4 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:12,758,970...12,762,649
Ensembl chr10:12,758,972...12,762,584
|
|
G |
Paqr5 |
progestin and adipoQ receptor family member 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PAQR5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:62,431,867...62,513,688
Ensembl chr 8:62,431,867...62,513,688
|
|
G |
Paqr7 |
progestin and adipoQ receptor family member 7 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PAQR7 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 5:146,709,159...146,720,577
Ensembl chr 5:146,708,900...146,720,673
|
|
G |
Paqr9 |
progestin and adipoQ receptor family member 9 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PAQR9 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 8:96,114,249...96,116,546
|
|
G |
Pcare |
photoreceptor cilium actin regulator |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PCARE mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:23,749,700...23,758,424
Ensembl chr 6:23,749,757...23,758,169
|
|
G |
Pcdh8 |
protocadherin 8 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PCDH8 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr15:55,198,470...55,203,039
Ensembl chr15:55,198,459...55,205,872
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Bezafibrate] results in decreased expression of PCK1 mRNA; Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of PCK1 mRNA] |
CTD |
PMID:21549692 PMID:28708105 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pcolce |
procollagen C-endopeptidase enhancer |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PCOLCE mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
|
|
G |
Pde3b |
phosphodiesterase 3B |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of PDE3B mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PDE3B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:168,606,762...168,770,078
Ensembl chr 1:168,607,022...168,769,334
|
|
G |
Pde6a |
phosphodiesterase 6A |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of PDE6A mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of PDE6A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:54,676,863...54,748,640
Ensembl chr18:54,676,863...54,748,816
|
|
G |
Pde6c |
phosphodiesterase 6C |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PDE6C mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:235,909,583...235,965,435
Ensembl chr 1:235,909,775...235,965,315
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of PDGFRA mRNA |
CTD |
PMID:19001666 |
|
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrl |
platelet-derived growth factor receptor-like |
affects expression |
ISO |
Sodium Glutamate affects the expression of PDGFRL mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:51,347,929...51,407,850
Ensembl chr16:51,347,948...51,407,850
|
|
G |
Pdha2 |
pyruvate dehydrogenase E1 subunit alpha 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHA2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PDHA2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:229,872,300...229,873,848
|
|
G |
Pdhb |
pyruvate dehydrogenase E1 subunit beta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
|
|
G |
Pdhx |
pyruvate dehydrogenase complex, component X |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PDHX mRNA Sodium Glutamate results in increased expression of PDHX mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:89,372,248...89,431,779
Ensembl chr 3:89,371,497...89,431,773
|
|
G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of PDIA4 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PDIA4 mRNA; [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PDIA4 mRNA |
CTD |
PMID:20111022 PMID:22078008 |
|
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PDK1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of PDK4 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PDK4 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PECR mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
|
|
G |
Peli1 |
pellino E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PELI1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:95,254,274...95,309,168
Ensembl chr14:95,254,589...95,308,285
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PEMT mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
|
|
G |
Pepd |
peptidase D |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PEPD mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:87,536,650...87,681,233
Ensembl chr 1:87,536,609...87,681,231
|
|
G |
Pex1 |
peroxisomal biogenesis factor 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:30,519,950...30,558,953
Ensembl chr 4:30,519,955...30,558,921
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX11A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX11A mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:133,680,091...133,687,172
Ensembl chr 1:133,680,091...133,687,172
|
|
G |
Pex13 |
peroxisomal biogenesis factor 13 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr14:97,602,829...97,621,233
Ensembl chr14:97,603,539...97,621,262
|
|
G |
Pex5 |
peroxisomal biogenesis factor 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:157,270,671...157,296,432
Ensembl chr 4:157,270,672...157,296,431
|
|
G |
Pex7 |
peroxisomal biogenesis factor 7 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PEX7 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PEX7 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
|
|
G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PFKFB2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr13:42,147,473...42,174,699
Ensembl chr13:42,147,478...42,174,699
|
|
G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PFKFB4 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PFKFB4 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PGAM1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Phkb |
phosphorylase kinase regulatory subunit beta |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PHKB mRNA |
CTD |
PMID:19001666 |
|
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
|
|
G |
Phlpp2 |
PH domain and leucine rich repeat protein phosphatase 2 |
multiple interactions decreases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PHLPP2 mRNA Sodium Glutamate results in decreased expression of PHLPP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:37,835,125...37,901,804
Ensembl chr19:37,835,125...37,905,513
|
|
G |
Pi16 |
peptidase inhibitor 16 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PI16 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:7,376,073...7,385,386
Ensembl chr20:7,376,126...7,385,383
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
multiple interactions increases expression |
EXP |
Semaxinib inhibits the reaction [Sodium Glutamate results in increased expression of PIK3CA protein] |
CTD |
PMID:36732937 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pkdcc |
protein kinase domain containing, cytoplasmic |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PKDCC mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:11,455,686...11,465,002
Ensembl chr 6:11,455,686...11,465,556
|
|
G |
Pklr |
pyruvate kinase L/R |
increases expression |
EXP |
Sodium Glutamate results in increased expression of PKLR mRNA |
CTD |
PMID:26092479 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pla2g12b |
phospholipase A2, group XIIB |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PLA2G12B mRNA |
CTD |
PMID:20111022 |
|
NCBI chr20:27,369,196...27,389,517
Ensembl chr20:27,370,266...27,388,743
|
|
G |
Pla2g15 |
phospholipase A2, group XV |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PLA2G15 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:34,050,685...34,068,070
Ensembl chr19:34,050,694...34,068,063
|
|
G |
Pla2g2e |
phospholipase A2, group IIE |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PLA2G2E mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 5:151,121,363...151,127,147
Ensembl chr 5:151,121,439...151,126,821
|
|
G |
Plagl1 |
PLAG1 like zinc finger 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PLAGL1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of PLAUR mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plbd1 |
phospholipase B domain containing 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PLBD1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PLCG1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Pld2 |
phospholipase D2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLD2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
|
|
G |
Plekhh1 |
pleckstrin homology, MyTH4 and FERM domain containing H1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PLEKHH1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:97,839,288...97,888,712
Ensembl chr 6:97,839,288...97,888,709
|
|
G |
Plppr1 |
phospholipid phosphatase related 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PLPPR1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:63,437,457...63,725,286
Ensembl chr 5:63,437,816...63,763,835
|
|
G |
Plxnd1 |
plexin D1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PLXND1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
|
|
G |
Pmf1 |
polyamine-modulated factor 1 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of PMF1 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PMF1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 2:173,848,074...173,868,272
Ensembl chr 2:173,848,074...173,868,270
|
|
G |
Pmvk |
phosphomevalonate kinase |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PMVK mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
|
|
G |
Pnlip |
pancreatic lipase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PNLIP mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:257,774,012...257,811,656
Ensembl chr 1:257,798,581...257,811,654
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PNPLA3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Polg |
DNA polymerase gamma, catalytic subunit |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of POLG mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of POLG mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
|
|
G |
Poli |
DNA polymerase iota |
increases expression |
ISO |
Sodium Glutamate results in increased expression of POLI mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:64,116,774...64,134,373
Ensembl chr18:64,116,774...64,163,418
|
|
G |
Pomc |
proopiomelanocortin |
decreases secretion increases expression decreases expression |
EXP ISO |
Sodium Glutamate results in decreased secretion of POMC protein Sodium Glutamate results in increased expression of POMC mRNA; Sodium Glutamate results in increased expression of POMC protein Sodium Glutamate results in decreased expression of POMC mRNA |
CTD |
PMID:8071649 PMID:9662721 PMID:9794456 |
|
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression increases expression multiple interactions |
EXP ISO |
Sodium Glutamate results in decreased expression of PPARA mRNA Sodium Glutamate results in increased expression of PPARA mRNA [Bezafibrate co-treated with Sodium Glutamate] results in increased expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARA mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PPARA mRNA |
CTD |
PMID:21205225 PMID:21549692 PMID:21999347 PMID:23783067 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions affects response to substance increases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARG mRNA PPARG protein affects the susceptibility to Sodium Glutamate Sodium Glutamate results in increased expression of PPARG mRNA |
CTD |
PMID:15231871 PMID:21205225 PMID:23783067 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions decreases expression increases expression |
EXP ISO |
[Taurine co-treated with Sodium Glutamate] results in increased expression of PPARGC1A mRNA; [Taurine co-treated with Sodium Glutamate] results in increased expression of PPARGC1A protein; Taurine promotes the reaction [Sodium Glutamate results in increased expression of PPARGC1A protein] Sodium Glutamate results in decreased expression of PPARGC1A mRNA [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARGC1A mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PPARGC1A mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of PPARGC1A mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of PPARGC1A mRNA; Sodium Glutamate results in increased expression of and results in increased acetylation of PPARGC1A protein; SRT1720 inhibits the reaction [Sodium Glutamate results in increased acetylation of PPARGC1A protein]; SRT1720 promotes the reaction [Sodium Glutamate results in increased expression of PPARGC1A protein] |
CTD |
PMID:19001666 PMID:19724016 PMID:20111022 PMID:23783067 PMID:25211138 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of PPP3R1 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PPP3R1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:91,556,743...91,606,391
Ensembl chr14:91,604,121...91,606,907
|
|
G |
Pprc1 |
PPARG related coactivator 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of PPRC1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PRDX2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PRDX5 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of PRDX5 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Prg4 |
proteoglycan 4 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of PRG4 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PRG4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:62,487,257...62,504,657
Ensembl chr13:62,487,257...62,504,119
|
|
G |
Prss23 |
serine protease 23 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PRSS23 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PSAT1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
|
|
G |
Psmc2 |
proteasome 26S subunit, ATPase 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMC2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
|
|
G |
Psmd14 |
proteasome 26S subunit, non-ATPase 14 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMD14 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:46,254,338...46,347,076
Ensembl chr 3:46,254,330...46,347,076
|
|
G |
Psmd9 |
proteasome 26S subunit, non-ATPase 9 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMD9 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:33,337,182...33,357,468
|
|
G |
Ptafr |
platelet-activating factor receptor |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of PTAFR mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PTGER3 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptms |
parathymosin |
increases expression |
EXP |
Sodium Glutamate results in increased expression of PTMS mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
|
|
G |
Pvt1 |
Pvt1 oncogene |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PVT1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:93,656,528...93,879,938
|
|
G |
Pwwp3b |
PWWP domain containing 3B |
increases expression |
ISO |
Sodium Glutamate results in increased expression of PWWP3B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:102,804,416...102,838,580
Ensembl chr X:102,804,520...102,838,574
|
|
G |
Pxmp2 |
peroxisomal membrane protein 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of PXMP2 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
|
|
G |
Pxmp4 |
peroxisomal membrane protein 4 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of PXMP4 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:143,093,371...143,110,620
Ensembl chr 3:143,093,018...143,110,651
|
|
G |
Rai14 |
retinoic acid induced 14 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of RAI14 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:59,546,284...59,682,687
Ensembl chr 2:59,546,284...59,681,971
|
|
G |
Ran |
RAN, member RAS oncogene family |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of RAN mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of RAN mRNA |
CTD |
PMID:20111022 |
|
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
|
|
G |
Rapgef6 |
Rap guanine nucleotide exchange factor 6 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RAPGEF6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:38,655,854...38,824,227
Ensembl chr10:38,655,867...38,823,211
|
|
G |
Rarb |
retinoic acid receptor, beta |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of RARB mRNA |
CTD |
PMID:20111022 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasgrp2 |
RAS guanyl releasing protein 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of RASGRP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:203,705,777...203,722,993
Ensembl chr 1:203,707,481...203,722,993
|
|
G |
Rassf7 |
Ras association domain family member 7 |
affects expression |
ISO |
Sodium Glutamate affects the expression of RASSF7 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:196,319,600...196,323,787
Ensembl chr 1:196,320,902...196,323,770
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
increases expression increases phosphorylation |
EXP |
Sodium Glutamate results in increased expression of RB1 mRNA Sodium Glutamate results in increased phosphorylation of RB1 protein |
CTD |
PMID:28954212 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbm4 |
RNA binding motif protein 4 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of RBM4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:202,078,442...202,087,506
Ensembl chr 1:202,085,279...202,105,380
|
|
G |
Rbp4 |
retinol binding protein 4 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of RBP4 protein [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RBP4 protein |
CTD |
PMID:19001666 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rbpjl |
recombination signal binding protein for immunoglobulin kappa J region-like |
increases expression |
ISO |
Sodium Glutamate results in increased expression of RBPJL mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:153,134,044...153,147,421
Ensembl chr 3:153,134,140...153,146,513
|
|
G |
Rcn1 |
reticulocalbin 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RCN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
|
|
G |
Rcn3 |
reticulocalbin 3 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RCN3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:95,564,503...95,573,762
Ensembl chr 1:95,564,380...95,573,725
|
|
G |
Rdh9 |
retinol dehydrogenase 9 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of RDH9 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 7:63,642,305...63,645,149
|
|
G |
Recql |
RecQ like helicase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of RECQL mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases expression |
EXP ISO |
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of RELA protein Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of RELA mRNA] |
CTD |
PMID:21999347 PMID:28708105 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rest |
RE1-silencing transcription factor |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of REST mRNA SB 203580 inhibits the reaction [Sodium Glutamate results in increased expression of REST mRNA] |
CTD |
PMID:16782274 |
|
NCBI chr14:30,859,109...30,879,828
Ensembl chr14:30,862,553...30,894,354
|
|
G |
Retn |
resistin |
increases expression decreases expression affects expression increases secretion multiple interactions |
ISO |
Sodium Glutamate results in increased expression of RETN mRNA; Sodium Glutamate results in increased expression of RETN protein Sodium Glutamate results in decreased expression of RETN; Sodium Glutamate results in decreased expression of RETN mRNA Sodium Glutamate affects the expression of RETN protein Sodium Glutamate results in increased secretion of RETN protein Glycine affects the reaction [Sodium Glutamate affects the expression of RETN protein]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of RETN mRNA]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased secretion of RETN protein]; Plant Extracts inhibits the reaction [Sodium Glutamate results in increased expression of RETN mRNA] |
CTD |
PMID:12208498 PMID:15809509 PMID:18930730 PMID:21205225 PMID:27918843 |
|
NCBI chr12:1,710,881...1,712,621
Ensembl chr12:1,710,881...1,712,620
|
|
G |
Rexo1 |
RNA exonuclease 1 homolog |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of REXO1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:9,154,050...9,174,035
Ensembl chr 7:9,154,061...9,173,454
|
|
G |
Rgs3 |
regulator of G-protein signaling 3 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of RGS3 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
|
|
G |
Rida |
reactive intermediate imine deaminase A homolog |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RIDA mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
|
|
G |
Riox2 |
ribosomal oxygenase 2 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of RIOX2 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr11:40,861,365...40,884,782
Ensembl chr11:40,860,774...40,884,574
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ROCK1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Romo1 |
reactive oxygen species modulator 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ROMO1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:144,659,709...144,661,310
Ensembl chr 3:144,659,826...144,661,310
|
|
G |
Rps27l |
ribosomal protein S27-like |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RPS27L mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
|
|
G |
Rps29 |
ribosomal protein S29 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of RPS29 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 6:87,635,229...87,636,627
Ensembl chr 6:87,635,230...87,636,636
|
|
G |
Rras2 |
RAS related 2 |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of RRAS2 mRNA Sodium Glutamate results in increased expression of RRAS2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
|
|
G |
Rrp9 |
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein |
increases expression |
ISO |
Sodium Glutamate results in increased expression of RRP9 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 8:107,116,411...107,126,123
Ensembl chr 8:107,117,471...107,126,123
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of RT1-DB1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of S100A13 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:175,999,439...176,005,933
|
|
G |
S100a8 |
S100 calcium binding protein A8 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A8 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of S100A8 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
|
|
G |
Samd4b |
sterile alpha motif domain containing 4B |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of SAMD4B mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:83,689,413...83,728,652
Ensembl chr 1:83,689,413...83,713,853
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SCARB1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scarna17 |
small Cajal body-specific RNA 17 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SCARNA17 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr18:68,344,475...68,344,553
Ensembl chr18:68,344,475...68,344,553
|
|
G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] affects the expression of SCD2 mRNA Sodium Glutamate results in increased expression of SCD2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:243,169,171...243,182,231
Ensembl chr 1:243,169,236...243,182,232
|
|
G |
Scd4 |
stearoyl-coenzyme A desaturase 4 |
increases expression decreases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of SCD4 mRNA Sodium Glutamate results in decreased expression of SCD4 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SCD4 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SCD4 mRNA; [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of SCD4 mRNA |
CTD |
PMID:19001666 PMID:20111022 PMID:22078008 |
|
NCBI chr 1:243,203,433...243,216,007
Ensembl chr 1:243,203,881...243,215,148
|
|
G |
Scg5 |
secretogranin V |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SCG5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:100,544,099...100,588,463
|
|
G |
Scn9a |
sodium voltage-gated channel alpha subunit 9 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of SCN9A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:51,145,148...51,293,342
Ensembl chr 3:51,145,146...51,293,516
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SDHB mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of SDHB mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Sds |
serine dehydratase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SDS mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:36,083,226...36,090,540
Ensembl chr12:36,083,229...36,088,203
|
|
G |
Serpinb5 |
serpin family B member 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SERPINB5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
|
|
G |
Sfn |
stratifin |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of SFN mRNA |
CTD |
PMID:28954212 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sgpp1 |
sphingosine-1-phosphate phosphatase 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SGPP1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 6:94,425,339...94,446,534
Ensembl chr 6:94,425,339...94,446,534
|
|
G |
Sik1 |
salt-inducible kinase 1 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of SIK1 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of SIK1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT1 mRNA; [Resveratrol co-treated with Sodium Glutamate] results in increased expression of SIRT1 protein |
CTD |
PMID:23783067 PMID:28708105 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt2 |
sirtuin 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SIRT2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
|
|
G |
Ski |
Ski proto-oncogene |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of SKI mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:165,713,525...165,782,134
Ensembl chr 5:165,714,093...165,782,733
|
|
G |
Slc13a2 |
solute carrier family 13 member 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SLC13A2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC22A1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC22A18 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Slc25a1 |
solute carrier family 25 member 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC25A1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
|
|
G |
Slc25a10 |
solute carrier family 25 member 10 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC25A10 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
|
|
G |
Slc25a12 |
solute carrier family 25 member 12 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A12 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:56,097,166...56,191,841
Ensembl chr 3:56,097,269...56,192,100
|
|
G |
Slc25a25 |
solute carrier family 25 member 25 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of SLC25A25 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A25 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
|
|
G |
Slc25a33 |
solute carrier family 25 member 33 |
multiple interactions decreases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A33 mRNA Sodium Glutamate results in decreased expression of SLC25A33 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 5:160,195,040...160,219,961
Ensembl chr 5:160,195,042...160,219,961
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SLC26A4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC27A1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr16:18,278,984...18,300,173
Ensembl chr16:18,278,984...18,296,063
|
|
G |
Slc28a1 |
solute carrier family 28 member 1 |
multiple interactions decreases expression |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC28A1 mRNA Sodium Glutamate results in decreased expression of SLC28A1 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 1:135,079,375...135,122,791
Ensembl chr 1:135,081,385...135,122,464
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
[Rosiglitazone co-treated with Sodium Glutamate] results in decreased expression of SLC2A1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of SLC2A1 mRNA |
CTD |
PMID:18048028 PMID:19001666 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a12 |
solute carrier family 2 member 12 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC2A12 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 1:22,803,068...22,862,204
Ensembl chr 1:22,804,418...22,860,971
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions increases expression |
ISO |
Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A2 mRNA]; Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A2 protein] Sodium Glutamate results in increased expression of SLC2A2 mRNA; Sodium Glutamate results in increased expression of SLC2A2 protein |
CTD |
PMID:28708105 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
affects expression decreases expression multiple interactions increases expression |
EXP ISO |
Sodium Glutamate affects the expression of SLC2A4 mRNA; Sodium Glutamate affects the expression of SLC2A4 protein Sodium Glutamate results in decreased expression of SLC2A4 protein Atorvastatin inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 protein]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A4 mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of SLC2A4 protein]; Resveratrol inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 mRNA]; Resveratrol inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 protein]; Tea inhibits the reaction [Sodium Glutamate results in decreased expression of SLC2A4 protein] Carbenoxolone affects the reaction [Sodium Glutamate affects the expression of SLC2A4 mRNA]; Carbenoxolone affects the reaction [Sodium Glutamate affects the expression of SLC2A4 protein] Sodium Glutamate results in decreased expression of SLC2A4 mRNA; Sodium Glutamate results in decreased expression of SLC2A4 protein |
CTD |
PMID:11319642 PMID:19800637 PMID:22415589 PMID:25834641 PMID:28708105 PMID:29679905 PMID:31077719 More...
|
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc2a8 |
solute carrier family 2 member 8 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC2A8 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 3:16,274,918...16,284,536
Ensembl chr 3:16,274,925...16,284,464
|
|
G |
Slc35b1 |
solute carrier family 35, member B1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of SLC35B1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:80,327,921...80,335,279
Ensembl chr10:80,327,945...80,335,274
|
|
G |
Slc36a2 |
solute carrier family 36 member 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SLC36A2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr10:39,278,002...39,306,082
Ensembl chr10:39,278,046...39,306,082
|
|
G |
Slc38a4 |
solute carrier family 38, member 4 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of SLC38A4 mRNA [Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of SLC38A4 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 7:128,142,866...128,203,000
Ensembl chr 7:128,144,807...128,202,995
|
|
G |
Slc45a2 |
solute carrier family 45, member 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SLC45A2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:59,963,599...59,996,408
Ensembl chr 2:59,963,706...59,996,317
|
|
G |
Slc4a1 |
solute carrier family 4 member 1 (Diego blood group) |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of SLC4A1 mRNA |
CTD |
PMID:31569818 |
|
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
|
|
G |
Slc4a2 |
solute carrier family 4 member 2 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC4A2 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 4:10,736,419...10,754,407
Ensembl chr 4:10,736,425...10,752,965
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of SLC4A4 mRNA |
CTD |
PMID:31569818 |
|
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
|
|
G |
Slc6a1 |
solute carrier family 6 member 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of SLC6A1 mRNA |
CTD |
PMID:19733649 |
|
NCBI chr 4:147,448,961...147,482,295
Ensembl chr 4:147,466,965...147,482,293
|
|
G |
Slc6a2 |
solute carrier family 6 member 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SLC6A2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SLC8A1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of SLC8A1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Slc8a3 |
solute carrier family 8 member A3 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of SLC8A3 mRNA; Sodium Glutamate results in increased expression of SLC8A3 protein |
CTD |
PMID:20928830 |
|
NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SLPI mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
|
|
G |
Smad4 |
SMAD family member 4 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of SMAD4 mRNA |
CTD |
PMID:28954212 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smim3 |
small integral membrane protein 3 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of SMIM3 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr18:53,930,019...53,982,339
Ensembl chr18:53,930,020...53,957,416
|
|
G |
Snrnp35 |
small nuclear ribonucleoprotein U11/U12 subunit 35 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SNRNP35 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:32,112,032...32,119,829
Ensembl chr12:32,110,993...32,122,660
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
multiple interactions decreases expression |
EXP |
Sodium Glutamate inhibits the reaction [GH1 protein results in decreased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 mRNA]; Sodium Glutamate inhibits the reaction [GH1 protein results in increased expression of SOCS2 protein] Sodium Glutamate results in decreased expression of SOCS2 mRNA; Sodium Glutamate results in decreased expression of SOCS2 protein |
CTD |
PMID:25697375 |
|
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SOCS3 protein |
CTD |
PMID:24502529 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression multiple interactions increases expression |
ISO |
Sodium Glutamate results in decreased expression of SOD1 mRNA SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SOD1 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SOD1 protein] Sodium Glutamate results in increased expression of SOD1 mRNA; Sodium Glutamate results in increased expression of SOD1 protein |
CTD |
PMID:19724016 PMID:30733785 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sorl1 |
sortilin related receptor 1 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SORL1 mRNA Sodium Glutamate results in increased expression of SORL1 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr 8:42,341,704...42,504,435
Ensembl chr 8:42,341,704...42,504,513
|
|
G |
Sp1 |
Sp1 transcription factor |
increases expression |
EXP |
Sodium Glutamate results in increased expression of SP1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Spaar |
small regulatory polypeptide of amino acid response |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SPAAR mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:57,985,423...57,987,482
|
|
G |
Spon2 |
spondin 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of SPON2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Srbd1 |
S1 RNA binding domain 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SRBD1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 6:8,473,591...8,664,544
Ensembl chr 6:8,475,542...8,664,544
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions increases expression affects expression decreases expression |
EXP ISO |
Carbenoxolone affects the reaction [Sodium Glutamate affects the expression of SREBF1 mRNA] Sodium Glutamate results in increased expression of SREBF1 mRNA; Sodium Glutamate results in increased expression of SREBF1 protein Sodium Glutamate results in decreased expression of SREBF1 mRNA 3-(4-(4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl)pyrrolidin-2-ylcarbonyl)thiazolidine affects the reaction [[Dietary Fats co-treated with Sodium Glutamate] affects the expression of SREBF1 mRNA]; [Dietary Fats co-treated with Sodium Glutamate] affects the expression of SREBF1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of SREBF1 mRNA; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of SREBF1 protein] |
CTD |
PMID:19001666 PMID:19724016 PMID:26092479 PMID:26670228 PMID:31077719 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions increases expression decreases expression |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SREBF2 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of SREBF2 mRNA Sodium Glutamate results in increased expression of SREBF2 mRNA Sodium Glutamate results in decreased expression of SREBF2 mRNA |
CTD |
PMID:20111022 PMID:22078008 PMID:23783067 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
Srrm3 |
serine/arginine repetitive matrix 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SRRM3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:20,808,878...20,878,557
Ensembl chr12:20,809,089...20,878,505
|
|
G |
Sspo |
SCO-spondin |
increases expression |
ISO |
Sodium Glutamate results in increased expression of SSPO mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:77,394,915...77,450,526
Ensembl chr 4:77,397,059...77,450,412
|
|
G |
St6galnac4 |
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of ST6GALNAC4 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of STAT2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:702,565...718,349
Ensembl chr 7:702,495...718,967
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases phosphorylation |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of STAT3 mRNA Sodium Glutamate results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:23783067 PMID:24502529 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stk26 |
serine/threonine kinase 26 |
multiple interactions increases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of STK26 mRNA Sodium Glutamate results in increased expression of STK26 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:130,325,064...130,375,674
Ensembl chr X:130,310,885...130,374,291
|
|
G |
Stk35 |
serine/threonine kinase 35 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of STK35 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066
|
|
G |
Stk36 |
serine/threonine kinase 36 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of STK36 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:76,176,922...76,204,423
Ensembl chr 9:76,176,920...76,204,422
|
|
G |
Stx2 |
syntaxin 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of STX2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr12:27,678,744...27,714,751
Ensembl chr12:27,689,819...27,714,751
|
|
G |
Surf1 |
SURF1, cytochrome c oxidase assembly factor |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of SURF1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of SURF1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:10,241,793...10,244,686
Ensembl chr 3:10,241,837...10,263,315
|
|
G |
Syngap1 |
synaptic Ras GTPase activating protein 1 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of SYNGAP1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr20:5,026,366...5,056,659
Ensembl chr20:5,026,364...5,056,672
|
|
G |
Tac1 |
tachykinin, precursor 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of TAC1 mRNA |
CTD |
PMID:17307297 |
|
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
|
|
G |
Taf1a |
TATA-box binding protein associated factor, RNA polymerase I subunit A |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TAF1A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:95,012,160...95,048,131
Ensembl chr13:95,029,225...95,048,087
|
|
G |
Tal2 |
TAL bHLH transcription factor 2 |
multiple interactions decreases expression |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TAL2 mRNA Sodium Glutamate results in decreased expression of TAL2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:68,411,012...68,417,569
Ensembl chr 5:68,411,012...68,417,569
|
|
G |
Tas1r1 |
taste 1 receptor member 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TAS1R1 mRNA |
CTD |
PMID:25990784 |
|
NCBI chr 5:162,533,838...162,546,408
Ensembl chr 5:162,533,841...162,545,562
|
|
G |
Tas1r3 |
taste 1 receptor member 3 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TAS1R3 mRNA |
CTD |
PMID:25990784 |
|
NCBI chr 5:166,468,703...166,472,759
Ensembl chr 5:166,469,589...166,472,742
|
|
G |
Tat |
tyrosine aminotransferase |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TAT mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tfam |
transcription factor A, mitochondrial |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TFAM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TFAM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Tfr2 |
transferrin receptor 2 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of TFR2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr12:19,107,673...19,124,622
Ensembl chr12:19,107,673...19,124,591
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of TFRC mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Th |
tyrosine hydroxylase |
decreases activity decreases expression |
EXP |
Sodium Glutamate results in decreased activity of TH protein Sodium Glutamate results in decreased expression of TH mRNA |
CTD |
PMID:1980722 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thap2 |
THAP domain containing 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of THAP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:50,992,912...51,007,582
Ensembl chr 7:50,995,793...51,008,061
|
|
G |
Thbs1 |
thrombospondin 1 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of THBS1 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
|
|
G |
Tiprl |
TOR signaling pathway regulator |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TIPRL mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:77,527,176...77,552,026
Ensembl chr13:77,527,176...77,552,074
|
|
G |
Tmc6 |
transmembrane channel like 6 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TMC6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:102,982,059...102,999,509
Ensembl chr10:102,971,229...102,998,960
|
|
G |
Tmem106a |
transmembrane protein 106A |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TMEM106A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:86,506,908...86,515,915
Ensembl chr10:86,506,936...86,515,892
|
|
G |
Tmem190 |
transmembrane protein 190 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TMEM190 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:69,062,709...69,064,938
Ensembl chr 1:69,062,366...69,065,238
|
|
G |
Tmem260 |
transmembrane protein 260 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TMEM260 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr15:21,734,119...21,804,049
Ensembl chr15:21,734,151...21,806,801
|
|
G |
Tmem69 |
transmembrane protein 69 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of TMEM69 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TMEM69 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:130,004,888...130,008,466
Ensembl chr 5:130,004,901...130,010,655
|
|
G |
Tmprss11f |
transmembrane serine protease 11F |
affects expression |
ISO |
Sodium Glutamate affects the expression of TMPRSS11F mRNA |
CTD |
PMID:22078008 |
|
NCBI chr14:21,492,896...21,534,792
Ensembl chr14:21,429,418...21,534,809
|
|
G |
Tmprss2 |
transmembrane serine protease 2 |
multiple interactions increases expression |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of TMPRSS2 mRNA Sodium Glutamate results in increased expression of TMPRSS2 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr11:36,934,306...36,973,779
Ensembl chr11:36,934,306...36,973,715
|
|
G |
Tnf |
tumor necrosis factor |
increases expression affects expression multiple interactions |
ISO EXP |
Sodium Glutamate results in increased expression of TNF mRNA; Sodium Glutamate results in increased expression of TNF protein Sodium Glutamate affects the expression of TNF mRNA [Fats, Unsaturated co-treated with Sodium Glutamate] results in increased expression of TNF protein; [Sodium Glutamate co-treated with Aspartame] promotes the reaction [Fats, Unsaturated results in increased expression of TNF protein]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; Atorvastatin inhibits the reaction [Sodium Glutamate results in increased expression of TNF protein]; Glycine affects the reaction [Sodium Glutamate affects the expression of TNF mRNA]; Pioglitazone inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; Plant Extracts inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of TNF mRNA]; SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of TNF protein] [Fenofibrate co-treated with Sodium Glutamate] results in increased expression of TNF protein |
CTD |
PMID:18930730 PMID:19724016 PMID:19800637 PMID:21205225 PMID:21999347 PMID:23783067 PMID:27918843 PMID:28708105 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
increases secretion multiple interactions |
ISO |
Sodium Glutamate results in increased secretion of TNFRSF1B protein Plant Extracts inhibits the reaction [Sodium Glutamate results in increased secretion of TNFRSF1B protein] |
CTD |
PMID:27918843 |
|
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
G |
Tnfrsf4 |
TNF receptor superfamily member 4 |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of TNFRSF4 mRNA [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of TNFRSF4 mRNA |
CTD |
PMID:20111022 |
|
NCBI chr 5:166,606,909...166,609,599
Ensembl chr 5:166,606,909...166,609,599
|
|
G |
Tnfsf14 |
TNF superfamily member 14 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TNFSF14 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
|
|
G |
Tom1 |
target of myb1 membrane trafficking protein |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TOM1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:13,405,482...13,440,384
Ensembl chr19:13,405,501...13,440,384
|
|
G |
Tor3a |
torsin family 3, member A |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of TOR3A mRNA |
CTD |
PMID:19001666 |
|
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TRP53 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TRP53 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TPH1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
|
|
G |
Tpm4 |
tropomyosin 4 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TPM4 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
G |
Tppp3 |
tubulin polymerization-promoting protein family member 3 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of TPPP3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr19:33,345,897...33,349,610
Ensembl chr19:33,345,898...33,349,577
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of TRAF3IP2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
|
|
G |
Trib1 |
tribbles pseudokinase 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of TRIB1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
|
|
G |
Trim25 |
tripartite motif-containing 25 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TRIM25 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:73,812,818...73,831,271
Ensembl chr10:73,812,818...73,831,257
|
|
G |
Trpv5 |
transient receptor potential cation channel, subfamily V, member 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of TRPV5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
|
|
G |
Tspan1 |
tetraspanin 1 |
increases expression |
EXP |
Sodium Glutamate results in increased expression of TSPAN1 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr 5:129,646,139...129,659,383
Ensembl chr 5:129,646,993...129,652,017
|
|
G |
Tspan6 |
tetraspanin 6 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TSPAN6 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:97,092,394...97,099,659
Ensembl chr X:97,092,388...97,099,309
|
|
G |
Tti2 |
TELO2 interacting protein 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TTI2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:60,980,665...60,988,587
Ensembl chr16:60,979,039...60,988,569
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TUFM mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TXN1 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of TXNRD1 mRNA |
CTD |
PMID:25473020 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
decreases expression multiple interactions |
EXP |
Sodium Glutamate results in decreased expression of UBE2I protein Carbenoxolone inhibits the reaction [Sodium Glutamate results in decreased expression of UBE2I protein] |
CTD |
PMID:31077719 |
|
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
|
|
G |
Uck2 |
uridine-cytidine kinase 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of UCK2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
EXP ISO |
[Fenofibrate co-treated with Sodium Glutamate] results in increased expression of UCP2 mRNA [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UCP2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of UCP2 mRNA |
CTD |
PMID:21999347 PMID:23783067 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Unc5cl |
unc-5 family C-terminal like |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of UNC5CL mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 9:12,528,109...12,543,382
Ensembl chr 9:12,528,246...12,542,233
|
|
G |
Unc93a |
unc-93 homolog A |
increases expression |
ISO |
Sodium Glutamate results in increased expression of UNC93A mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 1:52,973,143...53,029,578
Ensembl chr 1:52,980,724...53,029,663
|
|
G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of UQCR11 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of UQCR11 mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 7:9,305,042...9,309,753
Ensembl chr 7:9,305,058...9,309,750
|
|
G |
Urod |
uroporphyrinogen decarboxylase |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of UROD mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of UROD mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:130,464,695...130,468,783
Ensembl chr 5:130,455,217...130,468,808
|
|
G |
Usp54 |
ubiquitin specific peptidase 54 |
multiple interactions |
ISO |
[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of USP54 mRNA |
CTD |
PMID:19001666 |
|
NCBI chr15:3,659,345...3,757,703
Ensembl chr15:3,659,240...3,757,711
|
|
G |
Vcan |
versican |
decreases expression multiple interactions |
ISO |
Sodium Glutamate results in decreased expression of VCAN mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of VCAN mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression multiple interactions |
EXP |
Sodium Glutamate results in increased expression of VEGFA mRNA; Sodium Glutamate results in increased expression of VEGFA protein [Semaxinib co-treated with Sodium Glutamate] results in increased expression of VEGFA protein |
CTD |
PMID:28755050 PMID:36732937 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfb |
vascular endothelial growth factor B |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of VEGFB protein |
CTD |
PMID:28755050 |
|
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
|
|
G |
Wdfy2 |
WD repeat and FYVE domain containing 2 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of WDFY2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr15:37,083,842...37,209,559
Ensembl chr15:37,042,987...37,209,304
|
|
G |
Wfdc5 |
WAP four-disulfide core domain 5 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of WFDC5 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 3:152,849,025...152,854,868
Ensembl chr 3:152,849,025...152,854,904
|
|
G |
Wnk3 |
WNK lysine deficient protein kinase 3 |
increases expression multiple interactions |
ISO |
Sodium Glutamate results in increased expression of WNK3 mRNA [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of WNK3 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:20,156,260...20,299,252
Ensembl chr X:20,157,041...20,296,821
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of XDH mRNA |
CTD |
PMID:23783067 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
G |
Yaf2 |
YY1 associated factor 2 |
multiple interactions |
ISO |
[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of YAF2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 7:124,444,152...124,499,688
Ensembl chr 7:124,444,152...124,499,928
|
|
G |
Yy2 |
YY2 transcription factor |
increases expression |
ISO |
Sodium Glutamate results in increased expression of YY2 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr X:37,438,425...37,442,047
Ensembl chr X:37,410,811...37,464,430
|
|
G |
Zfp13 |
zinc finger protein 13 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ZFP13 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr10:12,615,455...12,623,615
Ensembl chr10:12,615,190...12,623,615
|
|
G |
Zfp239 |
zinc finger protein 239 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ZFP239 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 4:151,029,431...151,039,283
Ensembl chr 4:151,029,405...151,039,529
|
|
G |
Zfp362 |
zinc finger protein 362 |
decreases expression |
ISO |
Sodium Glutamate results in decreased expression of ZFP362 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr 5:141,119,073...141,153,304
Ensembl chr 5:141,119,898...141,156,716
|
|
G |
Zfp42 |
zinc finger protein 42 |
increases expression |
ISO |
Sodium Glutamate results in increased expression of ZFP42 mRNA |
CTD |
PMID:22078008 |
|
NCBI chr16:48,836,463...48,845,443
Ensembl chr16:48,836,648...48,845,401
|
|
G |
Zfp423 |
zinc finger protein 423 |
decreases expression |
EXP |
Sodium Glutamate results in decreased expression of ZFP423 mRNA |
CTD |
PMID:20928830 |
|
NCBI chr19:19,111,213...19,407,373
Ensembl chr19:19,110,238...19,407,373
|
|
|
G |
Adgre4 |
adhesion G protein-coupled receptor E4 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of ADGRE4 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760
|
|
G |
Adgre5 |
adhesion G protein-coupled receptor E5 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of ADGRE5 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions decreases expression |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of AFP mRNA] S-Adenosylmethionine results in decreased expression of AFP mRNA |
CTD |
PMID:18098314 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases abundance multiple interactions |
ISO |
AHR protein results in decreased abundance of S-Adenosylmethionine PEMT protein promotes the reaction [AHR protein results in decreased abundance of S-Adenosylmethionine] |
CTD |
PMID:29416063 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alad |
aminolevulinate dehydratase |
increases activity |
ISO |
S-Adenosylmethionine results in increased activity of ALAD protein |
CTD |
PMID:9559101 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Hemin] results in increased expression of ALAS2 mRNA; catechol inhibits the reaction [[S-Adenosylmethionine co-treated with Hemin] results in increased expression of ALAS2 mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
App |
amyloid beta precursor protein |
increases secretion |
ISO |
S-Adenosylmethionine results in increased secretion of APP protein modified form |
CTD |
PMID:22906069 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
As3mt |
arsenite methyltransferase |
multiple interactions affects binding |
ISO |
Cysteine promotes the reaction [AS3MT protein binds to S-Adenosylmethionine]; Glutathione promotes the reaction [AS3MT protein binds to S-Adenosylmethionine]; S-Adenosylmethionine promotes the reaction [AS3MT protein binds to and results in increased methylation of arsenite]; tris(2-carboxyethyl)phosphine promotes the reaction [AS3MT protein binds to S-Adenosylmethionine] |
CTD |
PMID:22955273 PMID:24124590 PMID:25349987 |
|
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
S-Adenosylmethionine results in increased expression of ATF3 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atp7b |
ATPase copper transporting beta |
multiple interactions |
ISO |
ATP7B protein mutant form promotes the reaction [Betaine results in increased abundance of S-Adenosylmethionine] |
CTD |
PMID:22945834 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Bhmt2 |
betaine-homocysteine S-methyltransferase 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [BHMT2 protein results in increased metabolism of Vitamin U] |
CTD |
PMID:18230605 |
|
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
|
|
G |
Casp12 |
caspase 12 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of CASP12 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases activity |
ISO EXP |
S-Adenosylmethionine inhibits the reaction [Ethanol results in increased activity of CASP3 protein] S-Adenosylmethionine results in decreased activity of CASP3 protein |
CTD |
PMID:17869084 PMID:18571630 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of CAT protein] |
CTD |
PMID:22683606 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of CCN1 protein]; S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased stability of CCN1 mRNA] |
CTD |
PMID:37682722 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of CDH2 protein] |
CTD |
PMID:37682722 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression multiple interactions |
ISO |
S-Adenosylmethionine results in decreased expression of COL1A1 mRNA S-Adenosylmethionine inhibits the reaction [LEP protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:15983038 PMID:16996477 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
multiple interactions decreases expression |
ISO EXP |
S-Adenosylmethionine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A2 mRNA]; S-Adenosylmethionine inhibits the reaction [SP1 protein binds to COL1A2 promoter]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein binds to COL1A2 promoter] S-Adenosylmethionine results in decreased expression of COL1A2 mRNA |
CTD |
PMID:8878782 PMID:15983038 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
[tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of S-Adenosylmethionine] |
CTD |
PMID:16758261 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen affects the localization of CYCS protein] |
CTD |
PMID:22683606 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity multiple interactions |
ISO EXP |
S-Adenosylmethionine results in decreased activity of CYP2E1 protein S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol]; S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of Dimethylnitrosamine]; S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of Ethanol] S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased expression of CYP2E1 protein]; S-Adenosylmethionine promotes the reaction [Carbon Tetrachloride results in decreased expression of and results in decreased activity of CYP2E1 protein] |
CTD |
PMID:15763544 PMID:15983038 PMID:22683606 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
ISO |
[Levodopa co-treated with DDC] results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:11445284 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of DLG4 protein] |
CTD |
PMID:27624276 |
|
NCBI chr10:54,740,700...54,769,097
Ensembl chr10:54,739,470...54,767,153
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT1 protein] |
CTD |
PMID:22558281 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT3A protein] S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA] |
CTD |
PMID:18098314 PMID:22558281 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Arsenic] affects the expression of EGR1 mRNA; [S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of EGR1 promoter]] which results in decreased expression of EGR1 mRNA; S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of EGR1 promoter] |
CTD |
PMID:35490796 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased methylation of ESR1 promoter]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of ESR1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of ESR1 protein] |
CTD |
PMID:22558281 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fcgr1a |
Fc gamma receptor 1A |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of FCGR1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
increases abundance |
ISO |
FGF19 protein results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:29416063 |
|
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Fgl2 |
fibrinogen-like 2 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of FGL2 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Gbp2 |
guanylate binding protein 2 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of GBP2 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA]] |
CTD |
PMID:20146260 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of GREB1 mRNA] |
CTD |
PMID:22558281 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of GSR protein] |
CTD |
PMID:22683606 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gss |
glutathione synthetase |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid affects the expression of GSS mRNA]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid affects the expression of GSS mRNA]] |
CTD |
PMID:20146260 |
|
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of GSTM2 mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Hand2 |
heart and neural crest derivatives expressed 2 |
multiple interactions |
ISO |
[Progesterone co-treated with S-Adenosylmethionine] results in increased methylation of HAND2 promoter; S-Adenosylmethionine inhibits the reaction [Progesterone results in increased expression of HAND2 mRNA] |
CTD |
PMID:30892605 |
|
NCBI chr16:32,917,448...32,920,791
Ensembl chr16:32,917,823...32,919,891
|
|
G |
Hbb |
hemoglobin subunit beta |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HBB mRNA; catechol inhibits the reaction [[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HBB mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hdac9 |
histone deacetylase 9 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HMBS mRNA; catechol inhibits the reaction [[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HMBS mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Ifi44l |
interferon-induced protein 44-like |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of IFI44L mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mRNA] |
CTD |
PMID:17080400 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
S-Adenosylmethionine inhibits the reaction [Thioacetamide results in increased expression of IL1B protein] S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA] |
CTD |
PMID:17080400 PMID:19822164 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL2 mRNA] |
CTD |
PMID:17080400 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of IL2RG mRNA |
CTD |
PMID:18098314 |
|
NCBI chr X:66,395,330...66,399,026
Ensembl chr X:66,392,542...66,399,823
|
|
G |
Il36g |
interleukin 36, gamma |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of IL36G mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 3:6,948,323...6,954,485
Ensembl chr 3:6,948,297...6,954,480
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP ISO |
S-Adenosylmethionine inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA] |
CTD |
PMID:17080400 PMID:19822164 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Klf6 |
KLF transcription factor 6 |
decreases expression multiple interactions |
ISO |
S-Adenosylmethionine results in decreased expression of KLF6 mRNA S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of KLF6 mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [LEP protein results in increased expression of COL1A1 mRNA]; S-Adenosylmethionine inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA] |
CTD |
PMID:16996477 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Ltb |
lymphotoxin beta |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA] |
CTD |
PMID:17080400 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G |
Maf |
MAF bZIP transcription factor |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in increased expression of MAF protein]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAF protein]] |
CTD |
PMID:20146260 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Mafg |
MAF bZIP transcription factor G |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]] |
CTD |
PMID:20146260 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]] |
CTD |
PMID:15983038 PMID:16996477 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK3 protein modified form]] |
CTD |
PMID:15983038 PMID:16996477 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mat1a |
methionine adenosyltransferase 1A |
affects abundance increases chemical synthesis |
ISO |
MAT1A affects the abundance of S-Adenosylmethionine MAT1A protein results in increased chemical synthesis of S-Adenosylmethionine |
CTD |
PMID:8373829 PMID:12060674 |
|
NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
increases chemical synthesis |
ISO |
MAT2A protein results in increased chemical synthesis of S-Adenosylmethionine |
CTD |
PMID:8373829 |
|
NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
|
|
G |
Mbd2 |
methyl-CpG binding domain protein 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of MBD2 protein] |
CTD |
PMID:22558281 |
|
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
|
|
G |
Meg3 |
maternally expressed 3 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Arsenicals results in increased expression of MEG3 mRNA] |
CTD |
PMID:33033900 |
|
NCBI chr 6:128,491,808...128,524,010
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of MMP2 protein] |
CTD |
PMID:37682722 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
increases abundance |
ISO |
MTHFD1 protein results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:19033438 |
|
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
|
|
G |
Mtr |
5-methyltetrahydrofolate-homocysteine methyltransferase |
affects binding multiple interactions |
ISO |
S-Adenosylmethionine binds to MTR protein [glutathionylcobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form; [Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form; Aluminum inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Arsenic inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Glutathione inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Glutathione promotes the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Lead inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; mecobalamin inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Mercury inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form] |
CTD |
PMID:17477549 PMID:26989453 |
|
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of NDRG1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Arsenic] results in increased expression of NFE2L2 mRNA; S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:20146260 PMID:35490796 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:18404532 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nlgn3 |
neuroligin 3 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NLGN3 mRNA]; S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NLGN3 promoter]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 mRNA]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 protein]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in increased methylation of NLGN3 promoter] |
CTD |
PMID:27624276 |
|
NCBI chr X:66,427,926...66,457,378
Ensembl chr X:66,429,458...66,451,876
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
increases abundance |
ISO |
NR0B2 protein results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:29416063 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nrxn1 |
neurexin 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRXN1 mRNA]; S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NRXN1 promoter]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 mRNA]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 protein]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in increased methylation of NRXN1 promoter] |
CTD |
PMID:27624276 |
|
NCBI chr 6:3,177,788...4,323,848
Ensembl chr 6:3,177,897...4,322,710
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased expression of PARP1 mRNA] |
CTD |
PMID:35490796 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pde4b |
phosphodiesterase 4B |
multiple interactions |
ISO |
[[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; [S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP; S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] |
CTD |
PMID:21266552 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pemt |
phosphatidylethanolamine N-methyltransferase |
multiple interactions |
ISO |
PEMT protein promotes the reaction [AHR protein results in decreased abundance of S-Adenosylmethionine] |
CTD |
PMID:29416063 |
|
NCBI chr10:44,775,910...44,849,990
Ensembl chr10:44,775,911...44,850,013
|
|
G |
Pfn2 |
profilin 2 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of PFN2 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:142,067,104...142,072,938
|
|
G |
Psmb8 |
proteasome 20S subunit beta 8 |
increases expression |
ISO |
S-Adenosylmethionine results in increased expression of PSMB8 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of PTGS1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Arsenic] affects the expression of PTGS2 mRNA; [S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA; S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of PTGS2 promoter] |
CTD |
PMID:35490796 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein] |
CTD |
PMID:21266552 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rnasel |
ribonuclease L |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of RNASEL mRNA |
CTD |
PMID:18098314 |
|
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of H2-EB1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
affects abundance |
ISO |
SLC19A1 protein affects the abundance of S-Adenosylmethionine |
CTD |
PMID:15705887 |
|
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
|
|
G |
Smyd2 |
SET and MYND domain containing 2 |
affects binding |
ISO |
S-Adenosylmethionine binds to SMYD2 protein |
CTD |
PMID:21782458 |
|
NCBI chr13:101,425,270...101,466,576
Ensembl chr13:101,425,273...101,466,576
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
ISO |
[S-Adenosylmethionine co-treated with Arsenic] affects the expression of SOCS3 mRNA; [S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of SOCS3 promoter]] which results in decreased expression of SOCS3 mRNA; S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of SOCS3 promoter] |
CTD |
PMID:35490796 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of SOD1 protein] |
CTD |
PMID:22683606 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of SOD2 protein] |
CTD |
PMID:22683606 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK3 protein modified form]] S-Adenosylmethionine inhibits the reaction [SP1 protein binds to COL1A2 promoter] |
CTD |
PMID:15983038 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Syn1 |
synapsin I |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of SYN1 protein] |
CTD |
PMID:27624276 |
|
NCBI chr X:1,172,208...1,227,400
Ensembl chr X:1,172,208...1,227,396
|
|
G |
Tf |
transferrin |
multiple interactions increases expression |
EXP |
[S-Adenosylmethionine results in increased expression of TF protein] which affects the abundance of Iron |
CTD |
PMID:18571630 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of TFF1 mRNA] |
CTD |
PMID:22558281 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tfrc |
transferrin receptor |
decreases expression |
EXP |
S-Adenosylmethionine results in decreased expression of TFRC mRNA |
CTD |
PMID:18571630 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK3 protein modified form]] S-Adenosylmethionine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein binds to COL1A2 promoter]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15983038 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
[[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] S-Adenosylmethionine inhibits the reaction [Thioacetamide results in increased expression of TNF protein] |
CTD |
PMID:19822164 PMID:21266552 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tpmt |
thiopurine S-methyltransferase |
multiple interactions |
ISO |
[S-Adenosylmethionine analog co-treated with TPMT protein] results in increased methylation of 4-methylbenzenethiol; [S-Adenosylmethionine analog co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol; [S-Adenosylmethionine co-treated with TPMT protein] results in increased methylation of 4-methylbenzenethiol; [S-Adenosylmethionine co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol; S-Adenosylmethionine analog inhibits the reaction [[S-Adenosylmethionine co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol]; S-Adenosylmethionine inhibits the reaction [[S-Adenosylmethionine analog co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol] |
CTD |
PMID:20196537 |
|
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
|
|
G |
Ubd |
ubiquitin D |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of UBD mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639 Ensembl chr20:1,385,864...1,408,639
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [monobutyl phthalate results in increased expression of VIM mRNA]; S-Adenosylmethionine inhibits the reaction [monobutyl phthalate results in increased expression of VIM protein] S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of VIM protein] |
CTD |
PMID:26745512 PMID:37682722 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased expression of XRCC1 mRNA] |
CTD |
PMID:35490796 |
|
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|